<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39562788</article-id><article-id pub-id-type="pmc">PMC11576971</article-id>
<article-id pub-id-type="publisher-id">54399</article-id><article-id pub-id-type="doi">10.1038/s41467-024-54399-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>TBK1-associated adapters TANK and AZI2 protect mice against TNF-induced cell death and severe autoinflammatory diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2176-5585</contrib-id><name><surname>Ujevic</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8816-1594</contrib-id><name><surname>Knizkova</surname><given-names>Daniela</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6854-4405</contrib-id><name><surname>Synackova</surname><given-names>Alzbeta</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pribikova</surname><given-names>Michaela</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Trivic</surname><given-names>Tijana</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Dalinskaya</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1066-9413</contrib-id><name><surname>Drobek</surname><given-names>Ales</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8768-9039</contrib-id><name><surname>Niederlova</surname><given-names>Veronika</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Paprckova</surname><given-names>Darina</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>De Guia</surname><given-names>Roldan</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kasparek</surname><given-names>Petr</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4675-8995</contrib-id><name><surname>Prochazka</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Labaj</surname><given-names>Juraj</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fedosieieva</surname><given-names>Olha</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0002-2306-8481</contrib-id><name><surname>Roeck</surname><given-names>Bernhard Florian</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Mihola</surname><given-names>Ondrej</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Trachtulec</surname><given-names>Zdenek</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3352-392X</contrib-id><name><surname>Sedlacek</surname><given-names>Radislav</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2735-3311</contrib-id><name><surname>Stepanek</surname><given-names>Ondrej</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8658-4614</contrib-id><name><surname>Draber</surname><given-names>Peter</given-names></name><address><email>peter.draber@unil.ch</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024d6js02</institution-id><institution-id institution-id-type="GRID">grid.4491.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 116X</institution-id><institution>Laboratory of Immunity &#x00026; Cell Communication, Division BIOCEV, First Faculty of Medicine, </institution><institution>Charles University, </institution></institution-wrap>Vestec, Czech Republic </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045syc608</institution-id><institution-id institution-id-type="GRID">grid.418827.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 870X</institution-id><institution>Laboratory of Adaptive Immunity, </institution><institution>Institute of Molecular Genetics of the Czech Academy of Sciences, </institution></institution-wrap>Prague, Czech Republic </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/019whta54</institution-id><institution-id institution-id-type="GRID">grid.9851.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2165 4204</institution-id><institution>Department of Immunobiology, </institution><institution>University of Lausanne, </institution></institution-wrap>Epalinges, Switzerland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045syc608</institution-id><institution-id institution-id-type="GRID">grid.418827.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 870X</institution-id><institution>Czech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, </institution><institution>Institute of Molecular Genetics of the Czech Academy of Sciences, </institution></institution-wrap>Vestec, Czech Republic </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rcxh774</institution-id><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Institute for Genetics, CECAD Cluster of Excellence, </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045syc608</institution-id><institution-id institution-id-type="GRID">grid.418827.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 870X</institution-id><institution>Laboratory of Germ Cell Development, Division BIOCEV, </institution><institution>Institute of Molecular Genetics of the Czech Academy of Sciences, </institution></institution-wrap>Prague, Czech Republic </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>15</volume><elocation-id>10013</elocation-id><history><date date-type="received"><day>25</day><month>8</month><year>2023</year></date><date date-type="accepted"><day>5</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024, corrected publication 2025</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par2">The cytokine TNF can trigger highly proinflammatory RIPK1-dependent cell death. Here, we show that the two adapter proteins, TANK and AZI2, suppress TNF-induced cell death by regulating the activation of TBK1 kinase. Mice lacking either TANK or AZI2 do not show an overt phenotype. Conversely, animals deficient in both adapters are born in a sub-Mendelian ratio and suffer from severe multi-organ inflammation, excessive antibody production, male sterility, and early mortality, which can be rescued by TNFR1 deficiency and significantly improved by expressing a kinase-dead form of RIPK1. Mechanistically, TANK and AZI2 both recruit TBK1 to the TNF receptor signaling complex, but with distinct kinetics due to interaction with different complex components. While TANK binds directly to the adapter NEMO, AZI2 is recruited later via deubiquitinase A20. In summary, our data show that TANK and AZI2 cooperatively sustain TBK1 activity during different stages of TNF receptor assembly to protect against autoinflammation.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par3">Dysregulation of the TNF receptor signaling complex (TNF-RSC) promotes the onset of autoinflammatory conditions. Here the authors show that two adapter proteins, TANK and AZI2, mediate the recruitment of the kinase TBK1 to TNF-RSC to protect the mice from TNF-induced cell death and autoinflammation.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Cell death and immune response</kwd><kwd>Chronic inflammation</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001824</institution-id><institution>Grantov&#x000e1; Agentura &#x0010c;esk&#x000e9; Republiky (Grant Agency of the Czech Republic)</institution></institution-wrap></funding-source><award-id>21-25251S</award-id><principal-award-recipient><name><surname>Draber</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100004410</institution-id><institution>European Molecular Biology Organization (EMBO)</institution></institution-wrap></funding-source><award-id>4420</award-id><principal-award-recipient><name><surname>Draber</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100007543</institution-id><institution>Grantov&#x000e1; Agentura, Univerzita Karlova (Charles University Grant Agency)</institution></institution-wrap></funding-source><award-id>PRIMUS/20/MED/003</award-id><award-id>406322</award-id><principal-award-recipient><name><surname>Pribikova</surname><given-names>Michaela</given-names></name><name><surname>Draber</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100007397</institution-id><institution>Univerzita Karlova v Praze (Charles University)</institution></institution-wrap></funding-source><award-id>Cooperatio</award-id><award-id>UNCE/MED/016</award-id><principal-award-recipient><name><surname>Draber</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001823</institution-id><institution>Ministerstvo &#x00160;kolstv&#x000ed;, Ml&#x000e1;de&#x0017e;e a T&#x0011b;lov&#x000fd;chovy (Ministry of Education, Youth and Sports)</institution></institution-wrap></funding-source><award-id>SVV 260637</award-id><award-id>LM2023036</award-id><principal-award-recipient><name><surname>Sedlacek</surname><given-names>Radislav</given-names></name><name><surname>Draber</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100010661</institution-id><institution>EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)</institution></institution-wrap></funding-source><award-id>Programme EXCELES, LX22NPO5102</award-id><award-id>802878</award-id><award-id>Programme EXCELES, LX22NPO5103</award-id><principal-award-recipient><name><surname>Stepanek</surname><given-names>Ondrej</given-names></name><name><surname>Draber</surname><given-names>Peter</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100004240</institution-id><institution>Akademie V&#x0011b;d &#x0010c;esk&#x000e9; Republiky (Academy of Sciences of the Czech Republic)</institution></institution-wrap></funding-source><award-id>RVO 68378050</award-id><principal-award-recipient><name><surname>Stepanek</surname><given-names>Ondrej</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft (German Research Foundation)</institution></institution-wrap></funding-source><award-id>SFB1403 (414786233)</award-id><principal-award-recipient><name><surname>Roeck</surname><given-names>Bernhard Florian</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium f&#x000fc;r Bildung und Forschung (Federal Ministry of Education and Research)</institution></institution-wrap></funding-source><award-id>16LW0213</award-id><principal-award-recipient><name><surname>Roeck</surname><given-names>Bernhard Florian</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par4">Tumor necrosis factor (TNF) is a proinflammatory cytokine with a crucial role in mounting immune defenses. However, it is also involved in the progression of various autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, or psoriasis. The inflammatory effects of TNF are mediated primarily by the ubiquitously expressed TNF receptor 1 (TNFR1). Stimulation of this receptor activates diverse signaling pathways, including nuclear factor-&#x003ba;B (NF-&#x003ba;B) or mitogen-activated protein kinases (MAPK), leading to the transcription of genes coding proinflammatory and anti-apoptotic proteins. However, TNFR1 stimulation can also directly trigger cell death mediated by receptor-interacting protein kinase 1 (RIPK1)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Once recruited to the membrane-bound TNF receptor signaling complex (TNF-RSC), termed complex I, RIPK1 autophosphorylates itself and translocates to the cytoplasm, forming cell death-inducing complex II<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR3">3</xref></sup>. The interaction of RIPK1 with FADD and Caspase-8 triggers apoptosis. Alternatively, RIPK1 can bind and activate kinase RIPK3, which phosphorylates MLKL, leading to its oligomerization and pore formation in the plasma membrane and subsequent necroptosis<sup><xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref></sup>. In order to prevent complex II formation, RIPK1 is extensively modified by polyubiquitination and phosphorylation<sup><xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref></sup>.</p><p id="Par5">Upon assembly of TNF-RSC, the adapter TRADD recruits non-degradative ubiquitin ligases TRAF2-cIAP1-cIAP2, generating K63-ubiquitin linkages, which in turn recruit linear ubiquitin chain assembly complex (LUBAC) that creates linear (M1) ubiquitin linkages<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. The adapters TAB2/3 recruit kinase TAK1 to K63-ubiquitin chains, while the adapter NF-&#x003ba;B essential modulator (NEMO) enables the recruitment of I&#x003ba;B kinase &#x003b1; (IKK&#x003b1;) and IKK&#x003b2; to M1 polyubiquitin linkages, leading to the activation of MAPK and NF-&#x003ba;B signaling pathways<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. At the same time, activation of signaling responses is tightly regulated by deubiquitinases CYLD and A20<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Interestingly, NEMO also promotes the recruitment of TANK binding kinase 1 (TBK1), which has a dual function within TNF-RSC. On the one hand, TBK1 partially inhibits the activation of NF-&#x003ba;B and MAPK signaling pathways<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. On the other, it phosphorylates and inhibits RIPK1 activity to prevent TNF-induced cell death<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. Since the TBK1-mediated phosphorylation of RIPK1 functions as a separate cell death checkpoint from NF-&#x003ba;B-induced transcription of anti-apoptotic genes<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, even enhanced activation of the NF-&#x003ba;B pathway cannot prevent TNF-induced cell death in TBK1-deficient cells<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par6"><italic>Tbk1</italic><sup>&#x02212;/&#x02212;</sup> mice derived from the C57BL/6 strain die during embryonic development due to liver degeneration. This phenotype is rescued by ablation of TNFR1 or inactivation of RIPK1 kinase activity, indicating that it is driven by aberrant TNF-induced cell death<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. Similarly, mice harboring enzymatically inactive TBK1 suffer from embryonic lethality caused by increased RIPK1-induced cell death<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. <italic>Tbk1</italic><sup>&#x02212;/&#x02212;</sup> mice on the 129S5 background are viable, but they are born at decreased Mendelian frequency and suffer from autoinflammation and immune infiltrates in multiple organs<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Human patients lacking TBK1 developed a severe autoimmune disease that could be treated by blocking TNF<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. These findings collectively demonstrate the critical role of TBK1 in protecting against TNF-induced inflammation and cell death. TBK1 is also a potential target for cancer treatment, as its inhibition significantly potentiates anti-PD-L1 immunotherapy due to the enhanced apoptosis and necroptosis of tumor cells triggered by TNF and IFN&#x003b3;<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>.</p><p id="Par7">TBK1 is a pleiotropic kinase that modulates various processes, including metabolism, autophagy, interferon signaling, and cell death<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. The broad range of TBK1 functions stems from its ability to interact with different adapters that connect it with distinct signaling complexes<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Furthermore, TBK1 can directly bind to immune receptors, such as the stimulator of interferon genes (STING) that detects cytosolic DNA derived from intracellular pathogens<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. In the context of the TNF-RSC, TBK1 was proposed to be recruited via adapters TRAF family member associated NF-&#x003ba;B activator (TANK) and 5-azacytidine induced 2 (AZI2, also known as NAP1)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. However, the role of these two adapters in protecting against TNF-induced cell death has been enigmatic. <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> mice are born at the expected Mendelian ratio and appear normal, although they develop glomerulonephritis over time, which is mediated by aberrant MyD88-signaling<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> mice show no overt phenotype<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>.</p><p id="Par8">Here, we analyze whether TANK and AZI2 are partially redundant in protecting against TNF-driven autoinflammation. We show that combined deletion of TANK and AZI2 strongly suppresses TNF-induced activation of TBK1. This is associated with a modest increase in NF-&#x003ba;B signaling and a significant enhancement of TNF-induced cell death in TANK/AZI2-deficient cells. Consistently, mice lacking both proteins develop severe TNFR1-driven autoinflammatory illness. Altogether, TANK and AZI2 are crucial components of the TNF-RSC, protecting against aberrant TNF-induced signaling and cell death.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>TANK and AZI2 protect against TNF-induced cell death</title><p id="Par9">To investigate whether adapters TANK and AZI2 contribute to TNF-induced activation of TBK1, we generated murine stromal ST2 cell lines lacking TANK, AZI2, or both proteins using CRISPR/Cas9. We stimulated these cells with Strep-Flag tagged TNF (SF-TNF) for 15&#x02009;minutes and isolated the TNF-RSC through Flag immunoprecipitation from cellular lysates. Compared to wild-type (WT) cells, the recruitment and phosphorylation of TBK1 within the TNF-RSC were reduced in <italic>Tank</italic> knockout (KO) and abolished in <italic>Tank/Azi2</italic> double KO (DKO) cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a, b</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Adapters TANK and AZI2 are required for TNF-induced TBK1 activation.</title><p><bold>a</bold>, <bold>b</bold> Immunoblot analysis of TNF-RSC isolated from ST2 WT, <italic>Tank</italic><sup>KO</sup>, <italic>Azi2</italic><sup>KO</sup>, or <italic>Tank/Azi2</italic><sup>DKO</sup> cell lines. Cells were stimulated with SF-TNF (500&#x02009;ng/ml) as indicated, and lysates were subjected to anti-Flag immunoprecipitation. As a control, SF-TNF was added post-lysis to unstimulated samples. A representative experiment (<bold>a</bold>) and quantification of recruitment of indicated proteins to TNF-RSC from three independent experiments normalized to WT cells, mean&#x02009;+&#x02009;SEM (<bold>b</bold>). <bold>c</bold>, <bold>d</bold> Immunoblot analysis of lysates of ST2 WT, <italic>Tank</italic><sup>KO</sup>, <italic>Azi2</italic><sup>KO</sup>, or <italic>Tank/Azi2</italic><sup>DKO</sup> cells stimulated with TNF (100&#x02009;ng/ml) as indicated. A representative experiment (<bold>c</bold>) and quantification of three independent experiments normalized to the maximal response of WT cells, mean&#x02009;&#x000b1;&#x02009;SEM (<bold>d</bold>). Statistical analysis was based on the area under the curve (AUC) for particular cell lines in each experiment, one-way ANOVA (<italic>p</italic>-value shown) with Tukey&#x000b4;s post-tests. <bold>e</bold>, <bold>f</bold> Immunoblot analysis of lysates from ST2 WT or <italic>Tank/Azi2</italic><sup>DKO</sup> cells that were unstimulated or stimulated for 24&#x02009;h with TNF (250&#x02009;ng/ml) and zVAD (20&#x02009;&#x000b5;M) as indicated and subjected to RIPK1 immunoprecipitation. A representative experiment (<bold>e</bold>) and quantification of phosphorylated RIPK1 and cleaved Caspase-8 from three independent experiments normalized to WT cells stimulated with TNF alone, mean&#x02009;+&#x02009;SEM (<bold>f</bold>). <bold>g</bold> ST2 WT and <italic>Tank/Azi2</italic><sup>DKO</sup> cells were unstimulated or stimulated with TNF (100&#x02009;ng/ml), and the induction of cell death was monitored every 2&#x02009;h using the Incucyte imaging system. The mean&#x02009;&#x000b1;&#x02009;SEM from six separate experiments using two different <italic>Tank/Azi2</italic><sup>DKO</sup> ST2 clones is shown. Statistical analysis was based on the AUC for different cell lines and treatments in each experiment, one-way ANOVA (<italic>p</italic>-value shown) with Tukey&#x000b4;s post-tests. <bold>h</bold> ST2 WT and <italic>Tank/Azi2</italic><sup>DKO</sup> cells were unstimulated or stimulated with TNF (100&#x02009;ng/ml) alone or in the presence of zVAD (20&#x02009;&#x000b5;M), Nec-1s (20&#x02009;&#x000b5;M), or both inhibitors. Induction of cell death after 48&#x02009;h was measured using the Incucyte imaging system. The mean&#x02009;+&#x02009;SEM from six independent experiments using two different <italic>Tank/Azi2</italic><sup>DKO</sup> ST2 clones is shown, two-way ANOVA with Tukey&#x02019;s post-tests. n.s., not significant. #, nonspecific band.</p></caption><graphic xlink:href="41467_2024_54399_Fig1_HTML" id="d33e639"/></fig></p><p id="Par10">Subsequently, we analyzed the role of the two adapters in TNF-induced activation of signaling pathways. We observed that TBK1 activating phosphorylation at serine 172<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup> was reduced in <italic>Tank</italic><sup>KO</sup> cells compared to wild-type (WT) or <italic>Azi2</italic><sup>KO</sup> cells and strongly suppressed in <italic>Tank/Azi2</italic><sup>DKO</sup> cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>). In contrast, the induction of the NF-&#x003ba;B pathway, detected as activating phosphorylation of IKK&#x003b1;/&#x003b2;, was slightly but very reproducibly increased in cells lacking both adapters (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>). Similarly, a detailed time-course analysis of TNF-induced signaling revealed that while TBK1 phosphorylation was suppressed, IKK&#x003b1;/&#x003b2; activating phosphorylation was both enhanced and prolonged in <italic>Tank/Azi2</italic><sup>DKO</sup> cells compared to WT cells, which also correlated with prolonged phosphorylation of its downstream target p105 (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1a, b</xref>). Activated IKK&#x003b1;/&#x003b2; phosphorylates I&#x003ba;B&#x003b1;, which is rapidly degraded<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Indeed, I&#x003ba;B&#x003b1; was barely detectable 15&#x02009;minutes after TNF stimulation in both WT and <italic>Tank/Azi2</italic><sup>DKO</sup> cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1a, b</xref>). However, <italic>Tank/Azi2</italic><sup>DKO</sup> cells had a markedly prolonged phase of I&#x003ba;B&#x003b1; phosphorylation and degradation detected at 30&#x02009;minutes upon stimulation (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1a, c</xref>), which correlated with enhanced and prolonged phosphorylation of IKK&#x003b1;/&#x003b2;. Altogether, TANK and AZI2 adapters are required for TBK1 activating phosphorylation, while they partially suppress IKK&#x003b1;/&#x003b2; activation and the induction of NF-&#x003ba;B pathway. These results align with previous studies showing enhanced TNF-induced activation of&#x000a0;IKK&#x003b1;/&#x003b2; in TBK1-deficient cells<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>.</p><p id="Par11">TBK1 is not required to prevent spontaneous activation of RIPK1 and induction of cell death in unstimulated cells. However, it inhibits the autophosphorylation of RIPK1 on Serine 166 and subsequent proteolytic activation of Caspase-8 upon TNF stimulation<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. TNF-induced Caspase-8 cleavage was enhanced in <italic>Tank/Azi2</italic><sup>DKO</sup> cells compared to WT cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e, f</xref>). When cells were treated with TNF in the presence of the caspase inhibitor zVAD, which stabilizes complex II formation, we observed robust RIPK1 autophosphorylation in <italic>Tank/Azi2</italic><sup>DKO</sup> cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1e, f</xref>). In accord, real-time cell imaging revealed that <italic>Tank/Azi2</italic><sup>DKO</sup> cells were susceptible to TNF-induced cell death, which was partially inhibited by zVAD or the RIPK1 inhibitor Necrostatin-1s (Nec-1s) and rescued by simultaneous treatment with both inhibitors (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1g, h</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1d</xref>). Similarly, the detection of dead cells by propidium iodide (PI) uptake via flow cytometry revealed that <italic>Tank/Azi2</italic><sup>DKO</sup> cells are sensitive to TNF induced cell death (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1e</xref>). This method detected even higher proportion of TNF-induced cell death in <italic>Tank/Azi2</italic><sup>DKO</sup> cells, which likely reflects differences in sample preparation.</p><p id="Par12">Regulation of RIPK1 activity and NF-&#x003ba;B-induced transcription of anti-apoptotic genes are two separate cell death checkpoints. Blocking NF-&#x003ba;B activation with IKK&#x003b1;/&#x003b2; inhibitor TPCA-1 further potentiated TNF-induced cell death in <italic>Tank/Azi2</italic><sup>DKO</sup> ST2 cells (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1f</xref>), indicating that IKK&#x003b1;/&#x003b2;-mediated cell death checkpoint is operating in <italic>Tank/Azi2</italic><sup>DKO</sup> cells. We also observed strongly suppressed phosphorylation of TBK1, slightly enhanced phosphorylation of IKK&#x003b1;/&#x003b2;, and increased cell death upon TNF stimulation in human HeLa <italic>TANK/AZI2</italic><sup>DKO</sup> cells (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">1g&#x02013;j</xref>). Combined, these data suggest that TANK and AZI2 regulate TNF-induced signaling and cell death by enabling TBK1 recruitment to TNF-RSC.</p></sec><sec id="Sec4"><title>TANK and AZI2 protect against autoinflammatory disease in mice</title><p id="Par13">To investigate the potential redundant function of the adapters TANK and AZI2 in vivo, we generated <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> mice using the CRISPR/Cas9 approach (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a, b</xref>). As expected, <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> mice were born in normal ratios and were indistinguishable from their WT littermates (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c, d</xref>). In contrast, upon the breeding of <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup>/<italic>Tank</italic><sup>+/&#x02212;</sup> mice, we observed that the <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals were born at a markedly sub-Mendelian ratio, indicating partial embryonic lethality (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>). <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> pups exhibited delayed hair growth, and by four weeks of age, they completely lacked body hair except for the head and tail base regions (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>). Their fur eventually grew, but the mice developed severe dermatitis within a few months (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2e</xref>). The median survival of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals was only 25 weeks (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2f</xref>). These findings were confirmed in animal strains derived from independent founders harboring different mutations in <italic>Tank</italic> and <italic>Azi2</italic> alleles. In this case, we crossed <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup>/<italic>Azi2</italic><sup>+/&#x02212;</sup> mice to obtain <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals, which were again born at a low ratio and displayed delayed hair growth and short lifespan (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2a&#x02013;e</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title><italic>Tank/Azi2</italic><sup>DKO</sup> mice develop severe autoinflammation.</title><p><bold>a</bold>, <bold>b</bold> Translations of DNA sequences (<bold>a</bold>) and an example of routine PCR genotyping (<bold>b</bold>) of the indicated <italic>Tank</italic> and <italic>Azi2</italic> alleles. <bold>c</bold> Genotype and counts of pups born to parents of the indicated genotypes, two-tailed chi-square test. <bold>d</bold>, <bold>e</bold> Representative photographs of mice of the indicated genotype at the age of 4 weeks (<bold>d</bold>) and 20 weeks (<bold>e</bold>). <bold>f</bold> Survival curves of mice of the indicated genotype (<italic>n</italic>&#x02009;=&#x02009;15 per group), log-rank Mantel-Cox test. <bold>g</bold>&#x02013;<bold>i</bold> Tissue sections stained with H&#x00026;E or the indicated dye. Skin (<bold>g</bold>), kidney (<bold>h</bold>), or liver (<bold>i</bold>) samples were collected from 20-24-week-old mice of the indicated genotype. Representative images are based on the analysis of five mice per group. <bold>j</bold>&#x02013;<bold>n</bold> The concentration of different biochemical markers in the blood plasma collected from 20-24-week-old mice of the indicated genotype (<italic>n</italic>&#x02009;=&#x02009;6 per group), mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is shown) with Tukey&#x02019;s post-tests. n.s., not significant. The scale bar is 100&#x02009;&#x000b5;m.</p></caption><graphic xlink:href="41467_2024_54399_Fig2_HTML" id="d33e951"/></fig></p><p id="Par14">To elucidate the likely cause of death of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals, we analyzed organs isolated from 20-24-week-old mice by histology. No apparent differences were observed between WT, <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> mice at this age. In contrast, histological examination of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice tissue samples revealed a severe autoinflammatory disease affecting multiple organs. Hematoxylin and eosin (H&#x00026;E) staining of skin sections from <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice revealed extensive immune cell infiltrations. The subdermal fat was completely missing, which was also demonstrated by staining with picrosirius red that binds to collagen fibers (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2g</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2f</xref>). Kidney sections stained with H&#x00026;E displayed glomerulonephritis characterized by swollen glomeruli, and Congo red staining identified massive amyloid deposits in the kidneys (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2h</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2g</xref>). H&#x00026;E staining of liver sections revealed numerous granulomas and picrosirius red staining showed collagen-filled scars and bile duct fibrosis (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2i</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2h</xref>). The tissue damage in the skin, kidney, and liver in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals was accompanied by enhanced apoptosis detected by TUNEL staining (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2i</xref>). Additionally, we observed massive immune infiltrations in the pancreas, skeletal muscles, and white adipose tissues (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2j</xref>).</p><p id="Par15">The internal organ damage observed in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice was further confirmed by biochemical analysis of blood plasma. <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice exhibited significantly elevated urea, phosphate, potassium, and magnesium levels, indicating severe kidney damage, which was not observed in WT, <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> or <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> mice (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2j</xref>). Moreover, we detected substantial increases in serum levels of total bilirubin and aspartate aminotransferase (AST) in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice compared to WT animals or mice lacking either adapter alone, indicating liver damage (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2k</xref>). In terms of lipid metabolism, <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice exhibited a strongly decreased level of plasma cholesterol concentration, while the concentration of triglycerides remained unchanged in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice compared to WT animals (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">2k</xref>). High-density lipoprotein (HDL) concentration was lowered in <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup>, or <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> animals and further significantly decreased in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice as compared to WT mice (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2l</xref>). In contrast, the plasma concentration of low-density lipoprotein (LDL), which contributes to cholesterol build-up in arteries, was substantially elevated in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice. This was reflected by a very high ratio of LDL to HDL in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2l</xref>), indicating an increased risk for cardiovascular failure.</p><p id="Par16">Plasma albumin levels were decreased in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2m</xref>), which is consistent with ongoing autoinflammatory disease and liver malfunction. These animals exhibited increased concentrations of total plasma proteins, suggesting an elevation in serum globulins and potentially an imbalance of the immune system and antibody production (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2n</xref>). In conclusion, the shortened lifespan of <italic>Tank/Azi2</italic><sup>DKO</sup> animals seems to be caused by multiorgan inflammation. These findings provide strong evidence that TANK and AZI2 can compensate for each other in vivo to protect against severe autoinflammatory disease.</p></sec><sec id="Sec5"><title><italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice have dysregulated antibody production</title><p id="Par17">The increased concentration of globulins in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice prompted us to analyze the concentration of different antibody isotypes in plasma. <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> mice showed similar levels of plasma antibodies as WT animals. In contrast, <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> mice displayed increased concentrations of all antibody isotypes, as reported previously<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice had similar plasma concentrations of IgM, IgG1, IgG2a, IgG2b, and IgE antibodies to <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> animals, while IgA antibody levels were substantially increased (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title><italic>Tank/Azi2</italic><sup>DKO</sup> mice have dysregulated antibody production.</title><p><bold>a</bold> Titers of different antibody isotypes in the blood plasma from 20-24-week-old mice of the indicated genotype (n&#x02009;=&#x02009;5 for WT and <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup>, 6 for <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Tank/Azi2</italic><sup>DKO</sup>), mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is indicated) with Tukey&#x02019;s post-tests. <bold>b</bold> Representative photograph and weight of spleens isolated from 8-10-week-old WT and <italic>Tank/Azi2</italic><sup>DKO</sup> mice (<italic>n</italic>&#x02009;=&#x02009;4 per group), mean&#x02009;+&#x02009;SEM, unpaired two-tailed t-test. <bold>c</bold> H&#x00026;E staining of spleen tissue sections from 20-24-week-old mice of the indicated genotype. Representative images are based on analyzing samples from five mice per group. <bold>d</bold>, <bold>e</bold> Flow cytometry measurement of cellularity and viability of splenocytes from 8-12-week-old mice of the indicated genotype (<bold>d</bold>), followed by the analysis of splenic myeloid cells (CD3<sup>&#x02212;</sup>, CD19<sup>&#x02212;</sup>, NK1.1<sup>&#x02212;</sup>, CD11b<sup>+</sup>) separated into macrophages (CD11c<sup>&#x02212;</sup>, Ly6G<sup>&#x02212;</sup>), neutrophils (CD11c<sup>&#x02212;</sup>, Ly6G<sup>+</sup>), and dendritic cells (DC) (CD11c<sup>+</sup>) (<bold>e</bold>) (<italic>n</italic>&#x02009;=&#x02009;8 per group), mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is indicated) with Tukey&#x02019;s post-tests. <bold>f</bold>&#x02013;<bold>i</bold> Flow cytometry analysis of B cells from the spleen (<bold>f</bold>&#x02013;<bold>g</bold>) and lymph nodes (<bold>h</bold>, <bold>i</bold>) from 8-12-week-old mice (<italic>n</italic>&#x02009;=&#x02009;8 per group). The proportion of B cells (CD19<sup>+</sup>) (<bold>f</bold>, <bold>h</bold>) and the percentage of isotype-switched B cells (IgM<sup>&#x02212;</sup>, IgD<sup>&#x02212;</sup>) in organs isolated from the indicated mouse strains, mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is indicated) with Tukey&#x02019;s post-tests (<bold>g</bold>, <bold>i</bold>). n.s., not significant. The scale bar is 100&#x02009;&#x000b5;m.</p></caption><graphic xlink:href="41467_2024_54399_Fig3_HTML" id="d33e1303"/></fig></p><p id="Par18">Spleens from <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice were enlarged, especially when normalized to body weight (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). Their histological analysis by H&#x00026;E staining revealed disrupted splenic architecture with poorly distinguishable boundaries between white and red pulp (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>). Flow cytometry analysis of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> spleen demonstrated increased cell counts with normal splenocytes viability (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>). We detected massive splenic infiltration of macrophages and neutrophils, while the proportion of dendritic cells (DC) was decreased (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3e</xref>). The ratio of splenic B cells was similar in WT, <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup>, <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup>, and <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3f</xref>). Upon activation, mature IgD<sup>+</sup> IgM<sup>Low</sup> B cells undergo isotype switching to produce antibodies of different isotypes. <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice exhibited a substantial increase in the proportion of isotype-switched B cells, characterized as CD19<sup>+</sup> IgM<sup>&#x02212;</sup> IgD<sup>&#x02212;</sup>, which corresponds to the high concentration of antibodies observed in their plasma (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3g</xref>). Similarly, a highly increased percentage of isotype-switched B cells was observed in the lymph nodes (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3h, i</xref>).</p><p id="Par19">To elucidate whether the increased proportion of isotype-switched B cells is driven by ongoing autoinflammatory disease or is a cell-intrinsic process, we performed competitive bone-marrow transfer. Bone marrow cells from WT and <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice were mixed in a 1:1 ratio and transplanted into lethally irradiated mice. The emergence of immune cells derived from <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> progenitors was significantly suppressed compared to cells derived from WT progenitors (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3a, b</xref>). However, the percentage of isotype-switched B cells was substantially enhanced in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> compared to WT B cells in both spleen and lymph nodes (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">3c&#x02013;f</xref>). Altogether, our results indicate that TANK and AZI2 function as crucial but partially redundant regulators of hematopoiesis, isotype switching, and antibody production by B cells.</p></sec><sec id="Sec6"><title>Enhanced signaling and cell death in cells isolated from <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice</title><p id="Par20">Mouse embryonic fibroblasts (MEFs) isolated from <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> or <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> animals had decreased phosphorylation of TBK1, which was severely impaired in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> compared to WT cells (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4a, b</xref>). Similarly to <italic>Tbk1</italic><sup>&#x02212;/&#x02212;</sup> MEFs<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> MEFs had slightly increased activation of IKK&#x003b1;/&#x003b2;, JNK, and p38 MAPK signaling pathways (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4c, d</xref>). Moreover, the recruitment and phosphorylation of TBK1 within TNF-RSC were strongly reduced in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> MEFs compared to WT or <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup> MEFs, and this correlated with enhanced NEMO recruitment (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4e, f</xref>).</p><p id="Par21">TNF stimulation of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> bone marrow-derived macrophages (BMDMs) led to strongly suppressed phosphorylation of TBK1, which was accompanied by slightly enhanced activation of NF-&#x003ba;B and JNK MAPK signaling pathways (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a, b</xref>). The stimulation of BMDMs with TNF triggers the expression of TNF-induced genes that can be identified by RNA sequencing (RNAseq) (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4g</xref> and Supplementary Dataset&#x000a0;<xref rid="MOESM5" ref-type="media">1</xref>). <italic>Tank/Azi2</italic><sup>DKO</sup> BMDMs had enhanced basal expression of TNF-responsive genes, including transcription of anti-apoptotic genes <italic>Traf1</italic>, <italic>Cflar</italic>, <italic>Birc2</italic>, and <italic>Birc3</italic><sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>, which likely reflects the increased basal expression of TNF in these cells. The transcription of TNF-induced genes was further enhanced in <italic>Tank/Azi2</italic><sup>DKO</sup> compared to WT BMDMs upon TNF stimulation (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4c, d</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4h</xref>). In contrast, we did not observe increased transcription of anti-apoptotic Bcl2 family members after two hours of TNF stimulation (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4h</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>TNF-induced TBK1 activation is impaired in <italic>Tank/Azi2</italic><sup>DKO</sup> macrophages.</title><p><bold>a</bold>, <bold>b</bold> Immunoblot analysis of lysates of bone marrow-derived macrophages (BMDMs) isolated from WT or <italic>Tank/Azi2</italic><sup>DKO</sup> mice and stimulated with TNF (100&#x02009;ng/ml) as indicated. A representative experiment (<bold>a</bold>) and quantification of three independent experiments using BMDMs independently isolated from 3 animal pairs. Data were normalized to the maximal response of WT cells, mean&#x02009;&#x000b1;&#x02009;SEM (<bold>b</bold>). Statistical analysis was based on the AUC for each cell line, unpaired two-tailed t-test. <bold>c</bold>, <bold>d</bold> RNAseq analysis of WT and <italic>Tank/Azi2</italic><sup>DKO</sup> BMDMs stimulated for two hours with TNF (100&#x02009;ng/ml). The BMDMs were independently isolated from 3 pairs of animals, and RNA was isolated in five separate experiments. Heatmap shows the expression of selected TNF-responsive genes (<bold>c</bold>). Gene set enrichment analysis (GSEA) shows the enrichment of 105 genes induced by TNF stimulation (log<sub>2</sub> fold change &#x0003e;&#x02009;1 and padj &#x0003c;&#x02009;0.01; samples from WT and <italic>Tank/Azi2</italic><sup>DKO</sup> BMDMs were analyzed together). The ranked gene list represents the contrast between unstimulated <italic>Tank/Azi2</italic><sup>DKO</sup> and WT BMDMs (blue) or stimulated <italic>Tank/Azi2</italic><sup>DKO</sup> and WT BMDMs (red). The <italic>p</italic>-value was estimated using an adaptive multi-level split Monte-Carlo scheme in the fgsea R package (<bold>d</bold>). <bold>e</bold> Analysis of cell death induced upon TNF (100&#x02009;ng/ml) stimulation of WT or <italic>Tank/Azi2</italic><sup>DKO</sup> BMDMs. Induction of cell death was detected via the Incucyte imaging system. Mean&#x02009;+&#x02009;SEM from eight separate experiments using samples isolated from 4 animal pairs, two-way ANOVA with Tukey&#x02019;s post-tests. n.s., not significant. #, nonspecific band.</p></caption><graphic xlink:href="41467_2024_54399_Fig4_HTML" id="d33e1597"/></fig></p><p id="Par22"><italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> BMDMs had increased basal level of cell death, and TNF stimulation of these cells showed enhanced induction of cell death in comparison to WT cells (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4e</xref>). Altogether, these data demonstrate that increased activation of the NF-&#x003ba;B pathway and induction of anti-apoptotic genes in <italic>Tank/Azi2</italic><sup>DKO</sup> cells is not sufficient to prevent cell death caused by a block in TBK1 recruitment to TNF-RSC, which is required to control the activation of RIPK1.</p></sec><sec id="Sec7"><title>TNFR1 is the primary driver of autoinflammation in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice</title><p id="Par23">Since TBK1 activation is necessary to protect against TNF-induced lethality in vivo<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, we aimed to investigate the role of TANK and AZI2 in safeguarding against a sublethal dose of TNF administered via tail-vein injection. While WT, <italic>Tank</italic><sup>&#x02212;/&#x02212;</sup>, and <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> mice tolerated the injection well, <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals rapidly succumbed to the treatment (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5a</xref>). Intriguingly, the analysis of plasma of 20-24-week-old <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice, which suffer from autoinflammation, revealed significantly elevated plasma levels of proinflammatory cytokines TNF, IFN&#x003b3;, IL-1&#x003b2;, and IL-17, compared to WT mice (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5b</xref>). The increased susceptibility of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice to TNF-induced lethality, coupled with the increased levels of plasma TNF, prompted us to explore whether the autoinflammatory disease observed in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice is driven by aberrant TNFR1 signaling.</p><p id="Par24">We crossed <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals with a mouse strain deficient in TNFR1 (<italic>Tnfrsf1a</italic><sup>&#x02212;/&#x02212;</sup>) to obtain <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic> triple KO (TKO) mice. These animals were born at a nearly Mendelian ratio, indicating a substantial rescue of the embryonic lethality phenotype (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a</xref>). <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice did not experience the delayed hair growth observed at four weeks of age in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b</xref>) and did not develop dermatitis by 30 weeks of age (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5c</xref>). Importantly, the survival of <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice was significantly improved compared to <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice, indicating a substantial rescue of the phenotype (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5d</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><title>TNFR1 is the primary driver of autoinflammation in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice.</title><p><bold>a</bold> Genotype and counts of pups born to <italic>Tank</italic><sup>+/&#x02212;</sup><italic>/Azi2</italic><sup>&#x02212;/&#x02212;</sup><italic>/Tnfrsf1a</italic><sup>&#x02212;/&#x02212;</sup> parents, two-tailed chi-square test. (<bold>b, c</bold>) Representative photographs of mice of the indicated genotype at the age of 4 weeks (<bold>b</bold>) and 30 weeks (<bold>c</bold>). <bold>d</bold> Survival curves of mice of the indicated genotype (n&#x02009;=&#x02009;15 per group). The comparison with <italic>Tank/Azi2</italic><sup>DKO</sup> mice (based on Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) is shown in gray, log-rank Mantel-Cox test. <bold>e</bold>&#x02013;<bold>h</bold> Tissue sections stained with H&#x00026;E or the indicated dye. Skin (<bold>e</bold>), kidney (<bold>f</bold>), liver (<bold>g</bold>), or spleen (<bold>h</bold>) samples were collected from 20-24-week-old mice of the indicated genotype. Representative images are based on the analysis of five mice per group. <bold>i</bold>&#x02013;<bold>m</bold> The concentration of different biochemical markers in the blood plasma isolated from 20-24-week-old <italic>Azi2/Tnfrsf1a</italic>
<sup>DKO</sup> or <italic>Tank/Azi2/Tnfrsf1a</italic>
<sup>TKO</sup> mice (<italic>n</italic>&#x02009;=&#x02009;6 per group). The comparison with <italic>Tank/Azi2</italic><sup>DKO</sup> mice (based on Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) is shown in gray, mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is indicated) with Tukey&#x02019;s post-tests. <bold>n</bold>, <bold>o</bold> Flow cytometry analysis of the proportion of isotype-switched B cells (CD19<sup>+</sup>, IgM<sup>&#x02212;</sup>, IgD<sup>&#x02212;</sup>) in the spleen (<bold>n</bold>) and lymph nodes (<bold>o</bold>) isolated from 8-12-week-old mice of the indicated genotype (<italic>n</italic>&#x02009;=&#x02009;8 per group). The comparison with <italic>Tank/Azi2</italic><sup>DKO</sup> mice (based on Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) is shown in gray, mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is indicated) with Tukey&#x02019;s post-tests. n.s., not significant. The scale bar is 100&#x02009;&#x000b5;m.</p></caption><graphic xlink:href="41467_2024_54399_Fig5_HTML" id="d33e1876"/></fig></p><p id="Par25">Histological analysis of organs isolated from five months old <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice demonstrated that they did not suffer from autoinflammation and appeared similar to control <italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>DKO</sup> animals. Notably, <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice did not exhibit aberrant immune cell infiltration in the skin and had normal subdermal fat deposition (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5e</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5c</xref>). Furthermore, they did not show signs of glomerulonephritis or amyloid deposits in the kidneys, and the liver was devoid of granulomas and collagenous scars (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5f, g</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5d, e</xref>). Additionally, no immune infiltrations were detected in the pancreas, skeletal muscle, or white adipose tissue samples isolated from these animals (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5f</xref>). Finally, <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice displayed standard splenic architecture (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5h</xref>).</p><p id="Par26">Further evidence supporting the rescue of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice by TNFR1 ablation was obtained through plasma biochemical analysis. Normal plasma urea, phosphate, potassium, and magnesium levels indicated restored kidney function in <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> animals (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5i</xref>). Similarly, total plasma bilirubin and AST were at normal levels in these mice, indicating rescued liver function (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5j</xref>). Regarding lipid metabolism, the <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice exhibited comparable total cholesterol levels as control mice (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5g</xref>). The concentration of HDL, LDL, and the ratio between LDL and HDL were rescued in <italic>Tank</italic>/<italic>Azi/Tnfrsf1a</italic><sup>TKO</sup> mice (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5k</xref>). Finally, we observed no significant decrease in plasma albumin or increase in total protein concentration in <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice compared to control animals, indicating no significant increase in plasma globulins (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5l, m</xref>). <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice did not show significantly increased number of splenocytes compared to control animals (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5h</xref>) and had a normal proportion of B cells in spleen, albeit it was mildly increased in the lymph nodes (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5i</xref>). Importantly, <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> did not have significantly elevated proportion of isotype-switched B cells (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5n, o</xref>). These findings align with a previous report showing impaired isotype switching in B cells from <italic>Tnfrsf1a</italic><sup>&#x02212;/&#x02212;</sup> mice<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>.</p><p id="Par27">Interestingly, while <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> males could not produce offspring, <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> males were fertile (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5j</xref>). Histological analysis of the testes revealed that seminiferous tubules of the <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice harbored spermatozoa (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5k</xref>). However, their testes weight was decreased, and sperm count, sperm motility, and progressive sperm motility were substantially reduced compared to control <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> and <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> mice (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">5l, m</xref>). These results show that the autoinflammatory disease and male sterility observed in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice are primarily driven by TNFR1 signaling.</p></sec><sec id="Sec8"><title>RIPK1 activity partially mediates the phenotype of <italic>Tank/Azi2</italic><sup>DKO</sup> mice</title><p id="Par28">Given the crucial role of RIPK1 as a mediator of TNF-induced cell death<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, we aimed to investigate whether the expression of the kinase-dead form of RIPK1 (RIPK1<sup>KD</sup>) with the inactivating mutation D138A could rescue <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice. Introducing the inactivating mutation in only one RIPK1 allele in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/+</sup> mice largely prevented embryonic lethality and rescued hair growth (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a, b</xref>). Furthermore, male fertility was restored, and these mice were protected against the intravenous injection of a sublethal dose of TNF (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6a, b</xref>). The median survival of these animals was limited to nine months, representing a significant improvement compared to <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice, but not reaching the level observed in <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> animals (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c</xref>). Similarly, <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice, in which both RIPK1 alleles contained kinase-dead mutation, were born at a Mendelian ratio and appeared grossly normal even at nine months of age (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6c, d</xref>), but their median survival was not further improved (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><title>RIPK1 kinase activity promotes autoinflammation in <italic>Tank/Azi2</italic><sup>DKO</sup> mice.</title><p><bold>a</bold> Genotype and counts of pups born to parents of the indicated genotype, two-tailed chi-square test. <bold>b</bold> Representative photographs of 4-week-old mice of the indicated genotype. <bold>c</bold> Survival curves of mice of the indicated genotype (<italic>n</italic>&#x02009;=&#x02009;10 for <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup> and 15 for other groups). The comparison with <italic>Tank/Azi2</italic><sup>DKO</sup> mice (based on Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) is shown in gray, log-rank Mantel-Cox test. <bold>d</bold>&#x02013;<bold>g</bold> Tissue sections stained with H&#x00026;E or the indicated dye. Skin (<bold>d</bold>), kidney (<bold>e</bold>), liver (<bold>f</bold>), or spleen (<bold>g</bold>) samples were collected from 20-24-week-old mice of the indicated genotype. Representative images are based on the analysis of four mice per group. <bold>h</bold>&#x02013;<bold>l</bold> The concentration of different biochemical markers in the blood plasma isolated from 20-24-week-old <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup><italic>/Ripk1</italic><sup>KD/KD</sup> (<italic>n</italic>&#x02009;=&#x02009;5) or <italic>Tank/Azi2</italic><sup>DKO</sup><italic>/Ripk1</italic><sup>KD/KD</sup> mice (<italic>n</italic>&#x02009;=&#x02009;6). The comparison with <italic>Tank/Azi2</italic><sup>DKO</sup> mice (based on Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) is shown in gray, mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is indicated) with Tukey&#x02019;s post-tests. <bold>m</bold>, <bold>n</bold> Flow cytometry analysis of the proportion of isotype-switched B cells (CD19<sup>+</sup>, IgM<sup>&#x02212;</sup>, IgD<sup>&#x02212;</sup>) in the spleen (<bold>m</bold>) and lymph nodes (<bold>n</bold>) isolated from 8-12-week-old mice of the indicated genotype (<italic>n</italic>&#x02009;=&#x02009;6 per group). The comparison with <italic>Tank/Azi2</italic><sup>DKO</sup> mice (based on Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) is shown in gray, mean&#x02009;+&#x02009;SEM, one-way ANOVA (<italic>p</italic>-value is indicated) with Tukey&#x02019;s post-tests.&#x000a0;n.s., not significant. The scale bar is 100&#x02009;&#x000b5;m.</p></caption><graphic xlink:href="41467_2024_54399_Fig6_HTML" id="d33e2305"/></fig></p><p id="Par29">Histological analysis from five months old <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice revealed that the skin inflammation was fully rescued by ablation of RIPK1 kinase activity, and we observed typical deposition of subdermal fat that was not distinguishable from control <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> animals (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6d</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6e</xref>). Staining of the kidney sections did not show signs of glomerulonephritis or amyloid deposits (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6e</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6f</xref>). Similarly, no immune cell infiltrations were detected in samples from the pancreas, skeletal muscle, or white adipose tissue (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6g</xref>). However, to our surprise, we noticed a strong formation of granulomas in the liver of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice, accompanied by the formation of fibrotic scars (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6f</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6h</xref>). Furthermore, we detected disrupted splenic architecture in these mice (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6g</xref>).</p><p id="Par30">Biochemical analysis of the plasma from 20-24-week-old <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice revealed a slight but not significant increase in urea concentration. At the same time, the ionic balance was not changed compared to control <italic>Azi2</italic><sup>&#x02212;/&#x02212;</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> animals, suggesting that kidney function was not significantly impacted (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6h</xref>). Markers of liver damage, total bilirubin, and AST were increased in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice as compared to control animals, although we noticed a substantial variation between animals, and the differences in AST did not reach statistical significance (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6i</xref>). Interestingly, <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice exhibited impaired lipid metabolism, characterized by decreased levels of plasma cholesterol, HDL, and LDL (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6j</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6i</xref>), which accompanies liver disease in human patients and mouse models<sup><xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>.</p><p id="Par31">We observed a slight but not statistically significant decrease in albumin and an increase in total plasma protein concentration in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice, which indicated only a small rise in globulin production (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6k, l</xref>). The number of splenocytes and their viability was normal in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6j</xref>) and the percentage of B cells in the lymph nodes and in the spleen was not significantly different from control animals (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">6k</xref>). Interestingly, a high proportion of B cells in the spleen and lymph nodes of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice exhibited an isotype-switched phenotype compared to control animals, although not to the same extent as in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6m, n</xref>). Overall, our data indicate that inactivation of RIPK1 in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> mice rescues most of the autoinflammatory phenotype observed in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals. However, these mice still develop liver inflammation, accompanied by increased activation of B cells. Therefore, these observations suggest that the TNFR1-driven autoinflammation observed in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice is primarily, but not entirely, driven by RIPK1 kinase activity.</p></sec><sec id="Sec9"><title>TANK and AZI2 are differentially recruited to TNF-RSC</title><p id="Par32">Our results demonstrate that TANK and AZI2 have overlapping roles in recruiting TBK1 to TNF-RSC and protecting against TNF-induced cell death. However, although both TANK and AZI2 bind TBK1, they lack substantial sequential or structural homology<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, suggesting that they might have distinct functions in regulating TBK1 recruitment to TNF-RSC. To reveal the differences between these two adapters, we analyzed the kinetics of their association with TNF-RSC. We stimulated ST2 cells with SF-TNF for various durations and subsequently isolated TNF-RSC via Flag immunoprecipitation. TANK was strongly recruited at 15&#x02009;minutes and was dissociated from the complex 30&#x02009;minutes after TNF stimulation (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7a, b</xref>). The kinetics of TANK recruitment closely mirrored the recruitment of the adapter NEMO, which supports previous reports that these two proteins directly interact<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. In contrast, AZI2 recruitment to TNF-RSC peaked only after 30&#x02009;minutes of stimulation, and AZI2 subsequently remained associated with the complex. Interestingly, the recruitment kinetics of AZI2 were similar to those of the deubiquitinase A20 (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7a, b</xref>), which can remain associated with the complex for several hours due to the strong binding of A20 to M1-polyubiquitin chains while cleaving other ubiquitin linkage types<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. The analysis of TNF-RSC isolated from MEFs and human HeLa cell lines indicated similar recruitment kinetics for TANK and NEMO, while AZI2 recruitment was delayed and resembled that of A20 (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7a&#x02013;d</xref>).<fig id="Fig7"><label>Fig. 7</label><caption><title>TANK and AZI2 are differentially recruited to TNF-RSC.</title><p><bold>a</bold>&#x02013;<bold>d</bold> Immunoblot analysis of TNF-RSC isolated from WT ST2 cells (<bold>a</bold>, <bold>b</bold>) or WT and NEMO<sup>KO</sup> ST2 cells (<bold>c</bold>, <bold>d</bold>). Cells were stimulated with SF-TNF (500&#x02009;ng/ml) for the indicated time points, and lysates were subjected to anti-Flag immunoprecipitation. As a control, SF-TNF was added post-lysis to unstimulated samples. A representative experiment (<bold>a</bold>, <bold>c</bold>) and quantification of recruitment of indicated proteins to TNF-RSC from three independent experiments normalized to WT cells, mean&#x02009;+&#x02009;SEM (<bold>b</bold>, <bold>d</bold>). <bold>e</bold>, <bold>f</bold> Isolation of SF-TANK or SF-AZI2 via anti-Flag immunoprecipitation from HEK293FT cells transiently overexpressing these proteins with NEMO. A representative experiment (<bold>e</bold>) and quantification of three experiments normalized to WT cells, mean&#x02009;+&#x02009;SEM (<bold>f</bold>). <bold>g</bold>&#x02013;<bold>j</bold> Immunoblot analysis of TNF-RSC isolated from ST2 WT or A20<sup>KO</sup> cells (<bold>g</bold>, <bold>h</bold>) or NEMO-deficient HeLa cells reconstituted with NEMO<sup>WT</sup> or NEMO<sup>L227P</sup> (<bold>i</bold>, <bold>j</bold>), performed as in a-d. Representative experiments (<bold>g</bold>, <bold>i</bold>) and quantification of recruitment of indicated proteins to TNF-RSC from three (<bold>h</bold>) or four (<bold>j</bold>) independent experiments normalized to the WT cells, mean&#x02009;+&#x02009;SEM. #, nonspecific band.</p></caption><graphic xlink:href="41467_2024_54399_Fig7_HTML" id="d33e2639"/></fig></p><p id="Par33">It was previously reported that NEMO recruits both TANK and AZI2 to TNF-RSC<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. We confirmed these findings by showing that NEMO-deficient ST2 cells had a severe defect in the TANK, AZI2, and&#x000a0;TBK1 recruitment (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7c, d</xref>). Interestingly, our data revealed that NEMO was also required for A20 recruitment (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7c, d</xref>), consistent with similar observations made in the context of the IL-17 receptor signaling complex<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> and Lymphotoxin &#x003b2; (LT&#x003b2;) receptor signaling complex<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Furthermore, TNF-RSC isolated from the NEMO<sup>KO</sup> HeLa cell line did not contain TANK, AZI2, or A20 and reintroducing WT NEMO, but not NEMO lacking amino acids (AA) 211-240 required for TANK and AZI2 interaction<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>, restored the recruitment of these proteins (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7e, f</xref>). Therefore, NEMO is required to recruit TANK, AZI2, and also A20 to TNF-RSC.</p><p id="Par34">To elucidate whether TANK and AZI2 bind directly to NEMO, we overexpressed NEMO with SF-tagged TANK or AZI2 in HEK293FT cells. Upon cell lysis, we isolated SF-TANK and SF-AZI2 via Flag immunoprecipitation. While both adapters were associated with TBK1, only SF-TANK interacted directly with NEMO and induced TBK1 phosphorylation upon overexpression (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7e, f</xref>). This suggested that AZI2 is recruited to TNF-RSC in a NEMO-dependent manner but not through direct interaction. Since AZI2 and A20 required NEMO for their association with TNF-RSC, and their recruitment kinetics were closely correlated, we aimed to explore whether A20 enables AZI2 recruitment and retention within the complex. Indeed, A20<sup>KO</sup> ST2 cells failed to recruit AZI2 to the TNF-RSC (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7g, h</xref>), which was rescued by the reconstitution of these cells with A20 (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7g, h</xref>). Similarly, AZI2 recruitment was nearly abolished in HeLa cells deficient in A20 (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7i, j</xref>).</p><p id="Par35">Gene coding NEMO is located on the X chromosome, and its deficiency in males leads to prenatal lethality. However, specific mutations in this gene are tolerated, but male patients develop ectodermal dysplasia with immunodeficiency (EDA-ID). A previous study reported a patient diagnosed with EDA-ID due to L227P mutation in NEMO<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref></sup>, which is localized in the region AA211-240 required for A20, AZI2, and TANK recruitment to TNF-RSC (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">7e, f</xref>). To test whether this mutation impacts TNF-induced TBK1 phosphorylation, we expressed NEMO WT or NEMO L227P mutant in NEMO<sup>KO</sup> HeLa cells. Analysis of TNF-RSC revealed that TANK, AZI2, A20, and TBK1 are absent from the complex in cells expressing NEMO L227P (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7i, j</xref>). Interestingly, NEMO L227P association with TNF-RSC was enhanced compared to NEMO WT (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7i, j</xref>), which is in accord with our observation that ablation of TANK and AZI2 promotes NEMO recruitment (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4e, f</xref>).</p><p id="Par36">Altogether, our results indicate that during the initial stage of TNF-RSC assembly, TANK directly links TBK1 with NEMO. Subsequently, NEMO facilitates A20 association with M1-ubiquitin linkages within the complex<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, which promotes the recruitment of TBK1 through AZI2 (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8a</xref>). While NEMO is released at later time points to terminate the activation of NF-&#x003ba;B signaling, A20 and AZI2 remain associated with the complex, ensuring the presence of TBK1 in the late stages of complex formation (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8b</xref>). In this manner, TBK1 can remain associated with the TNF-RSC to control RIPK1 activation both at the early and late stages of complex assembly.<fig id="Fig8"><label>Fig. 8</label><caption><title>Regulation of TBK1 activity by adapters TANK and AZI2.</title><p><bold>a</bold>, <bold>b</bold> Schematic representation of the differential recruitment of TANK and AZI2 to TNF-RSC. NEMO is recruited to K63- and M1-ubiquitin linkages formed by cIAP1/2 and LUBAC, respectively. NEMO is associated with TANK-TBK1 and promotes recruitment of A20, which enables recruitment of AZI2-TBK1 (<bold>a</bold>). At a later time, NEMO and TANK-TBK1 are released from the TNF-RSC. However, A20 remains associated with the TNF-RSC due to M1-binding and keeps recruiting AZI2-TBK1 (<bold>b</bold>).</p></caption><graphic xlink:href="41467_2024_54399_Fig8_HTML" id="d33e2744"/></fig></p></sec></sec><sec id="Sec10" sec-type="discussion"><title>Discussion</title><p id="Par37">In the present work, we demonstrate that the proteins TANK and AZI2 play a crucial yet redundant role in recruiting TBK1 to TNF-RSC. Cell lines deficient in TBK1 show slightly augmented activation of NF-&#x003ba;B and MAPK signaling pathways and are sensitive to TNF-induced cell death<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. We observed similar effects in various TANK and AZI2-deficient cells, which have severe defects in TBK1 activation. Notably, although activation of the NF-&#x003ba;B pathway and production of antiapoptotic proteins is enhanced in <italic>Tank/Azi2</italic><sup>DKO</sup> cells, it is not sufficient to overcome the enhanced formation of cell death-inducing complex II. This is in accord with the notion that activation of NF-&#x003ba;B transcriptional responses and regulation of RIPK1 activity are two separate cell death checkpoints<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Although our data indicate that the major role of these two adapters is to enable the activation of TBK1 upon TNF stimulation, they may have additional functions in regulating immune homeostasis. For example, both adapters were described to interact with the kinase IKK&#x003b5;<sup><xref ref-type="bibr" rid="CR53">53</xref>&#x02013;<xref ref-type="bibr" rid="CR55">55</xref></sup>. Ablation of IKK&#x003b5; in mice does not lead to an overt phenotype, suggesting it is not required for protection against cell death<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. However, IKK&#x003b5; can partially compensate for TBK1 deficiency in specific settings, including TNF signaling<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>.</p><p id="Par38">The absence of either TANK or AZI2 in mice is well tolerated, indicating that these adapters can compensate for each other to preserve immune homeostasis in unchallenged mice. However, deficiency in both proteins triggers a severe autoinflammatory disease characterized by multiorgan inflammation, including glomerulonephritis, liver granulomas, dermatitis, and disruption of splenic architecture. Additionally, <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals have delayed hair growth and the absence of subdermal fat, but the precise cause of these features remains unclear. Even though the phenotype of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> mice is very severe, it does not result in complete embryonic lethality, as observed in TBK1 knockout mice on the C57BL/6 background<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>. This fits with our observation that TBK1 phosphorylation was strongly decreased, but not completely blocked, in the cytoplasm of <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> cells. TBK1 is activated via autophosphorylation or phosphorylation by IKK&#x003b1;/&#x003b2;<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. It is possible that in <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> cells, a portion of cytoplasmic TBK1 might be phosphorylated by IKK&#x003b1;/&#x003b2; and partially inhibit TNF-induced cell death.</p><p id="Par39">The deletion of TNFR1 rescued <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> animals, while the ablation of RIPK1 kinase activity provided substantial, but not complete, rescue. <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup>/<italic>Ripk1</italic><sup>KD/KD</sup> animals suffered from liver damage, which was accompanied by an increased proportion of isotype-switched B cells in these mice. Bone marrow transfer experiments demonstrated that <italic>Tank</italic>/<italic>Azi2</italic><sup>DKO</sup> B cells are intrinsically prone to undergo isotype switching, which is in accordance with a previous study showing that TBK1 is a negative regulator of IgA switching in B cells<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. Since B cells isolated from <italic>Tank</italic>/<italic>Azi2</italic>/<italic>Tnfrsf1a</italic><sup>TKO</sup> do not show an isotype-switched phenotype, it is likely that this process relies on TNFR1 signaling but does not require RIPK1 activity.</p><p id="Par40">One of our unexpected discoveries was that the absence of TANK and AZI2 leads to male sterility, which was rescued by the ablation of TNFR1 or the inactivation of RIPK1 kinase activity. This is intriguing since it shows that TNF-mediated cell death can be responsible for decreased sperm count and motility, indicating that aberrant TNF signaling might underlie fertility problems more broadly. Interestingly, TNF-induced necroptosis was suggested to promote the aging of the testes in WT mice<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. These data open the possibility that some cases of male infertility might be caused by aberrant TNF-induced cell death and could be treated by inhibition of this pathway.</p><p id="Par41">Although there is a significant functional compensation between TANK and AZI2 in vivo, they have different amino acid sequences and structures, suggesting that the existence of these two adapters is not simply due to the duplication of ancestral genes. Instead, they likely have distinct roles in controlling inflammation. Both proteins are recruited via NEMO but markedly differ in their recruitment kinetics. TANK binds directly to NEMO, which is associated with TNF-RSC during the initial stage of complex assembly. In contrast, AZI2 does not interact with NEMO but requires deubiquitinase A20, which is recruited to TNF-RSC in a NEMO-dependent manner. However, once part of the complex, A20 and AZI2 remain associated with M1-linked polyubiquitin chains even after NEMO is released<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Although the role of NEMO in recruiting A20 is surprising, it is in accordance with the previous study showing that short C-terminal NEMO deletion abolished recruitment of A20 to TNF-RSC and caused inflammatory disease in a human patient<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Our data suggest that TANK and AZI2 cooperate to enable TBK1 activation during the whole duration of TNF-RSC assembly.</p><p id="Par42">The role of TBK1 within TNF-RSC is to suppress RIPK1-mediated induction of cell death<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. RIPK1 interacts directly with TNFR1 and TRADD dead domains and is recruited to TNF-RSC independently on NEMO<sup><xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR62">62</xref></sup>. The existence of two TBK1 binding adapters, one recruited early via NEMO and the second recruited later via A20, ensures that TBK1 can regulate RIPK1 activity during different stages of TNF-RSC assembly. In accord with the critical role of NEMO in recruiting TANK, A20, AZI2, and TBK1 to the TNF-RSC, we identified that human NEMO mutation L227P prevents the recruitment of all these proteins. AlphaFold prediction of NEMO structure<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> indicates that this mutation is localized in the alpha helix segment and might cause broader protein assembly disruption. Therefore, other pathogenic NEMO mutations reported in human patients might also drive the disease due to the block in TBK1 activation and enhanced TNF-induced cell death.</p><p id="Par43">Combined, our results show that either TANK or AZI2 expression is sufficient to prevent the development of autoinflammatory disease. However, in the case of immune challenges, such as pathogen infection, where TNF is produced in substantial quantity for a long-term period, both adapters might be required to limit TNF-induced cell death and tissue damage. Albeit we focused on TNF signaling, it is likely that TANK and AZI2 recruit TBK1 to regulate downstream signaling from any receptor that employs NEMO and A20, such as NOD1/2, CD40, IL-1 receptor, or Toll-like receptor (TLR) family members<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. In accord, TBK1 and TANK were reported to suppress the NF-&#x003ba;B signaling pathways upon stimulation of various TLRs<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR65">65</xref>,<xref ref-type="bibr" rid="CR66">66</xref></sup>. However, whether TANK and AZI2 play a redundant role in regulating signaling from different immune receptors remains to be addressed. Collectively, our work establishes TANK and AZI2 as core components of TNF-RSC that recruit TBK1 to prevent aberrant cell death induction and subsequent development of autoinflammatory disease.</p></sec><sec id="Sec11"><title>Methods</title><sec id="Sec12"><title>Cell cultures and reagents</title><p id="Par44">All cell lines were cultured at 37&#x02009;&#x000b0;C in a humidified atmosphere with 5% CO<sub>2</sub> in complete Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium (DMEM) (Merck), which was supplemented with 10% fetal bovine serum (FBS) (Biosera) and 1% penicillin-streptomycin antibiotics (ATB) (Biosera). ST2 cells were kindly provided by J. Balounova, and HeLa, HEK293FT, &#x000d8;NX-Eco, and &#x000d8;NX-Ampho cells were kindly provided by T. Brdicka (both from the Institute of Molecular Genetics, Prague, Czech Republic). MEFs were derived from E11.5 mouse embryos and immortalized by transduction with SV40 large T antigen. To prepare BMDMs, bone marrow cells isolated from the tibia and femur of 8-9-week-old WT or <italic>Tank/Azi2</italic><sup>DKO</sup> mice were cultured in DMEM/10% FBS/ATB supplemented with 1% non-essential amino acids (Merck) and 25&#x02009;ng/ml M-CSF (Peprotech). The medium was changed after 2, 5, and 7 days. After 7 days, more than 95% of cells were positive for murine macrophage marker F4/80 as measured by flow cytometry. Subsequently, BMDMs were either directly used for experiments or cultivated with routine changing of the fully supplemented media every two days for up to 18 days. Cell lines were regularly tested for the presence of Mycoplasma using the Mycoplasmacheck services (Eurofins Genomics).</p><p id="Par45">The antibodies and reagents used in this study are listed as part of Supplementary Dataset&#x000a0;<xref rid="MOESM6" ref-type="media">2</xref>.</p></sec><sec id="Sec13"><title>Recombinant proteins and protein isolation</title><p id="Par46">All recombinant ligands contained the CD33 leader at the N-terminus, followed by a 6xHis Tag, which enabled the secretion and purification of proteins, respectively. In the case of SF-tagged ligands, 2xStrep and 1xFlag sequences were included. The ligands contained murine TNF (AA80-235) or human TNF (AA77-233) sequences. Mouse TNF was used to stimulate ST2 cells, MEFs, and BMDMs, while human TNF was used to stimulate HeLa cells.</p><p id="Par47">The coding sequences for individual ligands were prepared using the GeneArt Gene Synthesis service (Thermo Fisher Scientific) and inserted into the pcDNA3.1 vector. Plasmids were transfected into HEK293FT cells using polyethylenimine (PEI) transfection. After three days, cell supernatants containing the produced proteins were collected. Samples were loaded on a His GraviTrap TALON column (Cytiva), previously equilibrated with a purification buffer (50&#x02009;mM sodium phosphate, pH 7.4, 300&#x02009;mM NaCl). The columns were washed with a purification buffer containing 20&#x02009;mM imidazole and eluted with a purification buffer containing 350&#x02009;mM imidazole. Subsequently, the samples were loaded on a centrifugal filter (10&#x02009;kDa molecular weight cut-off, Millipore), washed several times with purification buffer to remove imidazole, and concentrated. The concentration of purified proteins was determined using NanoDrop One (Thermo Fisher Scientific). Finally, 50% glycerol was added, and for long-term storage, ligands were kept at &#x02212;80&#x02009;&#x000b0;C.</p></sec><sec id="Sec14"><title>Preparation of knockout cell lines and exogenous protein expression</title><p id="Par48">ST2 and HeLa cell lines deficient in specific proteins were prepared using the CRISPR-Cas9 approach. Sequences of target sites for particular genes were selected using the CHOPCHOP web tool<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> and inserted into pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmid number 48138)<sup><xref ref-type="bibr" rid="CR68">68</xref></sup>. The target sites are listed as part of Supplementary Dataset&#x000a0;<xref rid="MOESM6" ref-type="media">2</xref>. Obtained plasmids were transfected into cells using Lipofectamine 2000 (Invitrogen), and EGFP-positive cells were sorted using FACSAria&#x02122; Fusion (BD Biosciences). Single-cell clones were prepared, and the deficiency of a specific protein was verified by immunoblotting or sequencing of the DNA surrounding the target sites.</p><p id="Par49">To reintroduce the proteins of interest, the coding sequences for the specified proteins were inserted into a retroviral pBabe vector, which expresses the GFP marker under the SV40 promoter. All the constructs were sequenced. Subsequently, &#x000d8;NX-Eco cells (used for ST2 cells reconstitution) or &#x000d8;NX-Ampho cells (used for HeLa cells reconstitution) were transfected with the pBabe-GFP vector containing coding sequences for the indicated proteins or an empty vector, using Lipofectamine 2000. Supernatants were collected, filtered through a 0.2&#x02009;&#x003bc;l filter, and then incubated with target cells in the presence of 6&#x02009;&#x003bc;g/ml polybrene. The cells were subsequently centrifugated (1 230&#x02009;g, 30&#x02009;&#x000b0;C, 45&#x02009;min). GFP-positive cells were sorted using BD FACSAria&#x02122; Fusion.</p><p id="Par50">To express proteins in HEK293FT cells, cells were transfected with NEMO and SF-TANK (SF-tag added at C-terminus) or SF-AZI2 (SF-tag at N-terminus) coding vectors using PEI.</p></sec><sec id="Sec15"><title>Analysis of signaling pathways and immunoprecipitation</title><p id="Par51">ST2, MEF, BMDM, or HeLa cell lines were washed and incubated in serum-free DMEM for at least 30&#x02009;minutes. Subsequently, the cells were stimulated with mouse or human TNF (100&#x02009;ng/ml) for the specified time points. Next, the cells were lysed on ice in lysis buffer (30&#x02009;mM Tris, pH 7.4, 120&#x02009;mM NaCl, 2&#x02009;mM KCl, 2&#x02009;mM EDTA, 10% glycerol, 10&#x02009;mM chloroacetamide, Complete protease inhibitor cocktail, and PhosSTOP tablets (Roche)) containing 1% n-Dodecyl-&#x003b2;-D-Maltoside (DDM) (ThermoFisher Scientific). The lysates were incubated on ice for 30&#x02009;minutes and cleared by centrifugation (21 130&#x02009;g, 30&#x02009;minutes, 2&#x02009;&#x000b0;C). The cleared lysates were mixed with sodium dodecyl sulfate (SDS)-containing sample buffer, reduced by 50&#x02009;mM dithiothreitol (DTT), and heated at 92&#x02009;&#x000b0;C for 3&#x02009;minutes.</p><p id="Par52">To isolate TNF-RSC, the cells were stimulated with SF-TNF as indicated. After solubilizing the samples in lysis buffer containing 1% DDM, the cleared lysates were subjected to immunoprecipitation with anti-Flag M2 affinity agarose gel (Merck) overnight at 4&#x02009;&#x000b0;C. Alternatively, to isolate proteins overexpressed in HEK293FT cells, cleared lysates from cells overexpressing indicated proteins were incubated with M2 beads overnight at 4&#x02009;&#x000b0;C. The following day, M2 beads were washed with 0.1% DDM-containing lysis buffer four times. Beads were resuspended in an SDS sample buffer containing 50&#x02009;mM DTT to release immunoprecipitated proteins, and the samples were heated at 92&#x02009;&#x000b0;C for 3&#x02009;minutes.</p><p id="Par53">For the immunoprecipitation of RIPK1, cells were stimulated with TNF (250&#x02009;ng/ml) for 24&#x02009;h in the presence or absence of the caspase inhibitor zVAD (20&#x02009;&#x000b5;M). RIPK1 antibody was added to pre-cleared lysates for 2&#x02009;h. Subsequently, Protein A/G PLUS-Agarose (Santa Cruz Biotechnology) was added, and samples were incubated overnight at 4&#x02009;&#x000b0;C. Upon washing the beads in lysis buffer containing 0.1% DDM, beads were resuspended in SDS sample buffer containing 50&#x02009;mM DTT and heated at 92&#x02009;&#x000b0;C for 3&#x02009;minutes to elute the proteins.</p><p id="Par54">The obtained samples were analyzed by immunoblotting. The chemiluminescence from HRP-fused secondary antibodies was detected using Chemidoc<sup>TM</sup> MP Imaging System and analyzed using ImageLab software v6.1 (both Bio-Rad Laboratories).</p></sec><sec id="Sec16"><title>Analysis of cell death</title><p id="Par55">WT or TANK/AZI2-deficient ST2 cells, HeLa cells, or BMDMs were seeded on 96-well plates. The following day, cells were stimulated with mouse or human TNF (100&#x02009;ng/ml) in the presence of 125&#x02009;nM Incucyte Cytotox Red Dye (Sartorius) or 200&#x02009;nM YOYO3 dye (ThermoFisher Scientific) in DMEM/10% FBS/ATB. In some experiments, IKK&#x003b1;/&#x003b2; inhibitor TPCA-1 (5&#x02009;&#x000b5;M), caspase inhibitor zVAD (20&#x02009;&#x000b5;M), and/or RIPK1 inhibitor Nec-1s (20&#x02009;&#x000b5;M) were added. The induction of cell death was assessed at two-hour intervals using Incucyte Live-Cell Analysis Systems (Sartorius). Samples were analyzed in triplicates, and at least two images per well were captured.</p><p id="Par56">To determine the percentage of cell death of high-throughput live cell imaging data, custom-made software was developed<sup><xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR70">70</xref></sup>. In short, brightfield- and fluorescence images (for cell death marker acquisition) of different cell lines and stages of apoptosis, necroptosis, pyroptosis, and ferroptosis induction (healthy, 30-, 60- or 90 % cell death) were acquired using Incucyte Live-Cell Analysis Systems. For necroptosis induction, HT29, HeLa cells expressing RIP3, MEFs, SCLC, and U2OS cells were treated with TNF (100&#x02009;ng/ml), MCL1 inhibitor S63845 (5&#x02009;&#x003bc;M), and zVAD (10&#x02009;&#x000b5;M). For ferroptosis induction, HeLa, NIH-3T3, and HEK293 cells were treated with ferroptosis-inducing compound RSL3 (2&#x02009;&#x000b5;M for NIH-3T3 and HEK293 or 4&#x02009;&#x000b5;M for HeLa). For apoptosis induction, HeLa and SCLC cells were treated with Ccl-2 inhibitor ABT&#x02010;737 (5&#x02009;&#x003bc;M) and S63845 (5&#x02009;&#x003bc;M). For pyroptosis induction, BMDMs were preincubated for two hours with LPS (200&#x02009;ng/ml) and then treated with inflammasome inducer Nigericin (2.5&#x02009;&#x000b5;M). To validate the specificity of cell death induction, the respective inhibitors were used in control conditions: zVAD (10&#x02009;&#x000b5;M) for apoptosis, NSA (2&#x02009;&#x000b5;M) or Nec-1 (10&#x02009;&#x000b5;M) for necroptosis, Fer-1 (5&#x02009;&#x000b5;M) for ferroptosis and DSF (5&#x02009;&#x000b5;M) for pyroptosis. Various brightfield images were manually annotated and assembled into a data set for the training data generation. For this, the area of living and dead cells was labeled, whereby the live/dead classification was based on the presence or absence of a cell death marker. Additionally, the center of cells was labeled. This dataset was used to train a U-Net-based artificial intelligence network. This custom-made software allows the precise segmentation of cells and the prediction of whether a single cell is alive or dead using only a brightfield image as input. As output, masks of living and dead cells and their position are obtained, allowing the numerical assessment of living and dead cells. Based on those numbers, the % of cell death was calculated. Cell death prediction was validated by cell death marker.</p><p id="Par57">For analysis of cell death using flow cytometry, WT or <italic>Tank/Azi2</italic><sup>DKO</sup> ST2 cells in DMEM/10% FBS/ATB were pretreated with zVAD (20&#x02009;&#x000b5;M) and/or Nec-1s (20&#x02009;&#x000b5;M) for 15&#x02009;minutes at 37&#x02009;&#x000b0;C. Subsequently, TNF (250&#x02009;ng/ml) was added as indicated. Cells were incubated for 24&#x02009;h. After incubation, the supernatants containing dead cells were collected. The attached cells were detached with Trypsin/EDTA solution (Biosera) for 10&#x02009;minutes. Subsequently, they were collected, mixed together with the supernatant, centrifugated, and resuspended in PBS containing PI (Thermo Fisher Scientific). The proportion of dead cells was determined by detecting the percentage of PI-positive cells using the BriCyte E3 flow cytometer (Mindray).</p></sec><sec id="Sec17"><title>RNA sequencing</title><p id="Par58">WT and <italic>Tank/Azi2</italic><sup>DKO</sup> BMDMs were seeded on six-well plates and stimulated with mouse TNF (100&#x02009;ng/ml) for 2&#x02009;h. The BMDMs were independently obtained from 3 pairs of animals. Subsequently, cells were collected, and RNA was isolated in five separate experiments using the Zymo Research Kit (R1055). The cDNA libraries were prepared using the KAPA mRNA Hyperprep Kit (Roche KK8580). Single-end sequencing was performed on Illumina NextSeq 2000 using the NextSeq 2000 P3 Reagents (50 cycles) kit (Illumina 20046810). The quality of reads was verified using FastQC v0.11.7 and MultiQC v1.17 tools<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. The reads were aligned to mouse genome GRCm39 using salmon v1.10.0<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>. The quantification of results was done using R packages tximport v1.26.1<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. The downstream analysis, including normalization, raw count modeling, and differential expression analyzes on complete count matrices, as well as subsets of specific samples, was done using the R package DESeq2 v1.38.3<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>. The <italic>p</italic>-value was calculated using the Wald test in the DESeq2 R package and corrected for multiple comparisons with the Benjamini&#x02013;Hochberg procedure. The changes in gene expression are listed in Supplementary Dataset&#x000a0;<xref rid="MOESM5" ref-type="media">1</xref>. Visualization and gene set enrichment analysis were performed with the packages EnhancedVolcano v1.16.0, pheatmap v1.0.12, and fgsea v1.24.0. The analysis was done on R v4.2.1.</p></sec><sec id="Sec18"><title>Mice</title><p id="Par59">The mice were housed in a specific-pathogen-free facility at the Institute of Molecular Genetics of the Czech Academy of Sciences (IMG) in compliance with the laws of the Czech Republic. All animal protocols for the mice experiments were approved by the Resort Professional Commission for Approval of Projects of Experiments on Animals of the Czech Academy of Sciences, Czech Republic. The mice were provided with a standard rodent breeding diet and water ad libitum. The animal facility maintained a 12-h light and 12-h dark cycle, with a temperature of 22&#x02009;&#x000b1;&#x02009;1&#x02009;&#x000b0;C and a relative humidity of 55&#x02009;&#x000b1;&#x02009;5%. Experimental and control animals were co-housed, with both males and females included in the study. Experimental mice were euthanized by cervical dislocation or by isofluorane inhalation at overdose.</p><p id="Par60">The murine strains utilized in this study were generated at the Czech Center for Phenogenomics at IMG. To introduce targeted indel mutations into the <italic>Tank</italic> and <italic>Azi2</italic> genes, a mixture containing Cas9 mRNA (100&#x02009;ng/ml) and target-specific sgRNA (50&#x02009;ng/ml) was microinjected into zygotes derived from C57BL/6&#x02009;N mice. Zygote electroporation was employed to deliver sgRNAs targeting <italic>Tnfrsf1a</italic> and <italic>Ripk1</italic> genes, as described elsewhere<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. In the case of producing the RIPK1<sup>KD</sup> allele harboring the inactivating D138N mutation, a single-stranded DNA template (10&#x02009;&#x003bc;M) was included. The resulting embryos were then implanted into foster mothers.</p><p id="Par61">Genomic DNA was isolated from tail biopsies of newborn mice, and the DNA sequence surrounding the CRISPR/Cas9 recognition site was amplified by PCR using Phusion polymerase (Thermo Fisher Scientific). Subsequently, the amplified DNA was sequenced. The selected founders were backcrossed onto the C57BL/6&#x02009;J background for at least three generations. Genotyping primers were designed to distinguish between the WT and modified alleles using Taq DNA polymerase (Top-Bio). The sequences of the oligonucleotides used for generating the mice and their genotyping can be found in Supplementary Dataset&#x000a0;<xref rid="MOESM6" ref-type="media">2</xref>.</p></sec><sec id="Sec19"><title>Clinical biochemistry and histology</title><p id="Par62">To collect blood samples, mice were placed under terminal isoflurane anesthesia. Retro-orbital sinus bleeding was performed using glass capillaries, and the blood was collected in lithium heparin-coated tubes. After collection, each tube was gently inverted to ensure proper mixing and then kept at room temperature. The samples were centrifuged within one hour of collection (5 000&#x02009;g, 10&#x02009;minutes, 8&#x02009;&#x000b0;C). The resulting plasma samples were frozen at &#x02212;80&#x02009;&#x000b0;C until further analysis. Biochemical parameters were analyzed using the AU480 clinical chemistry analyzer (Beckman Coulter). The analysis included measuring the concentrations of urea, phosphate, potassium, magnesium, total bilirubin, AST, cholesterol, triglycerides, HDL, LDL, albumin, and total protein. The concentrations of globulins were calculated as the difference between the total protein and albumin concentrations. The concentration of cytokines and antibody isotypes in the plasma was measured using the Bio-Plex 200 system (Bio-Rad). The Bio-Plex Pro Mouse Cytokine Th17 Panel A (Bio-Rad) was utilized to detect cytokines. Antibody Isotyping 7-Plex Mouse ProcartaPlex (Invitrogen) assay was employed to evaluate antibody concentrations.</p><p id="Par63">Tissue samples from the back skin, kidney, liver, spleen, pancreas, skeletal muscle, white adipose tissue, and testes of 20-24-week-old mice were fixed in 4% formaldehyde solution in PBS overnight and transferred to 70% ethanol. The samples were processed by the Leica ASP6025 Vacuum Tissue Processor according to the program Standard processing overnight, embedded in Paraplast X-tra (Leica Biosystems), using the Tissue Embedding Station Leica EG1150. The five &#x003bc;m thick sections were prepared using the Leica Fully Motorized Rotary Microtome RM2255-FU. The obtained slides were stained by Hematoxylin H (Biognost) and Eosin Y (Carl Roth) using the Leica ST5010-CV5030 Stainer Integrated Workstation. Congo red staining was done by using the Congo red Staining Kit (Roche) in Ventana Staining Machine for Special Stains (Roche) according to producer manuals. Picrosirius red staining was done manually using Weigert&#x02019;s Iron Hematoxylin Set and Direct Red 80 (Merck) according to producer protocol. To detect apoptotic cells, tissue samples were stained using TUNEL Assay Kit HRP-DAB (Abcam) according to the manufacturer&#x02019;s instructions. Apoptotic cells with exposed 3&#x02019;-OH ends of DNA fragments were marked by terminal deoxynucleotidyl transferase-mediated addition of biotinylated deoxynucleotides and detected by staining with streptavidin conjugated to horseradish peroxidase (HRP), followed by the addition of diaminobenzidine (DAB). Samples were counterstained with methyl green. Images of histological slides were obtained using the Axio Scan Z1 (Zeiss) scanner and evaluated in the software ZEN v3.4 (Zeiss). The average thickness of the subdermal fat layer was calculated by measuring 5 different locations in the skin of each analyzed animal. The proportion of swollen glomeruli was calculated from 1&#x02009;mm&#x02009;&#x000d7;&#x02009;1&#x02009;mm areas. The number of liver granulomas was calculated from 2&#x02009;mm&#x000a0;&#x000d7;&#x000a0;2&#x02009;mm areas.</p></sec><sec id="Sec20"><title>Analysis of immune cell populations</title><p id="Par64">Spleen and peripheral lymph nodes were removed from 8&#x02013;12-week-old mice and minced to obtain single-cell suspensions. In the case of the spleen, red blood cells were lysed in ACK buffer (150&#x02009;mM NH<sub>4</sub>Cl, 10&#x02009;mM KHCO<sub>3</sub>, 0.1&#x02009;mM EDTA- Na<sub>2</sub>, pH&#x02009;7.4). Cells were resuspended in FACS buffer and stained on ice with LIVE/DEAD near-IR dye (Invitrogen).</p><p id="Par65">To analyze B cells, the samples were stained with the following antibody panel: CD19-PE, IgM-BV421, IgD-PerCP_Cy5.5, CD23-APC, and CD1d-PE-Cy7. B cells (CD19<sup>+</sup>) were gated to identify isotype-switched cells (IgM<sup>&#x02212;</sup>, IgD<sup>&#x02212;</sup>).</p><p id="Par66">For the analysis of myeloid cells, the samples were stained with the following antibody panel: CD3-FITC, CD19-FITC, NK1.1-FITC, CD11b-BV421, CD11c-AF700, Ly6C-PE-Cy7, and Ly6G-AF647. Myeloid cells (CD3<sup>&#x02212;</sup>, CD19<sup>&#x02212;</sup>, NK1.1<sup>&#x02212;</sup>, CD11b<sup>+</sup>) were separated into three subsets: monocytes/macrophages (CD11c<sup>&#x02212;</sup>, Ly6G<sup>&#x02212;</sup>), neutrophils (CD11c<sup>&#x02212;</sup>, Ly6G<sup>+</sup>), and dendritic cells (CD11c<sup>+</sup>). All the fluorescently labeled antibodies are listed as part of Supplementary Dataset&#x000a0;<xref rid="MOESM6" ref-type="media">2</xref>.</p><p id="Par67">Samples were measured on Cytek Aurora flow cytometer, and data were analyzed using FlowJo software v10.10.0 (BD Biosciences). The gating strategy is shown in Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">8</xref>.</p></sec><sec id="Sec21"><title>Bone marrow transfer</title><p id="Par68">Bone marrow was isolated from 4&#x02013;5-week-old <italic>Tank/Azi2</italic><sup>DKO</sup> mice harboring Ly5.2 or WT mice expressing Ly5.1/5.2. Cells were mixed in a 1:1 ratio, and 2&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells in 200&#x02009;&#x000b5;l of PBS were intravenously injected into lethally irradiated (6&#x02009;Gy) 6-week-old recipient Ly5.1 mice. After 12&#x02013;14 weeks, the spleen and lymph nodes were harvested and analyzed by flow cytometry.</p></sec><sec id="Sec22"><title>Male fertility and sperm count</title><p id="Par69">To evaluate male fertility, males of the specified genotype were paired with WT females for a maximum duration of 40 days or until pups were born, after which the males were separated. The number of newborn pups was recorded.</p><p id="Par70">Sperm count was obtained after thorough mincing of epididymides in PBS at room temperature using a Burker chamber. Motility was determined as previously described<sup><xref ref-type="bibr" rid="CR76">76</xref></sup> on sperm isolated by puncturing the epididymides and capacitation in Toyoda-Yokoyama-Hosi (TYH) medium at 37 &#x000b0;C and 5% CO<sub>2</sub> for one hour. The Computer-assisted sperm analysis system (Hamilton-Thorne, version 12.3, standard settings for mouse sperm) with Leja slides (double chamber, 0.1&#x02009;mm deep) was employed to assess the percentage of motile and progressively motile spermatozoa via video recordings of over one thousand cells per male.</p></sec><sec id="Sec23"><title>Statistics and reproducibility</title><p id="Par71">The used statistical tests are indicated. In the case of one-way ANOVA, two-way ANOVA, and unpaired two-tailed <italic>t</italic>-test, the normality was assessed using the Kolmogorov-Smirnov test or Shapiro-Wilk test. Statistical analysis was performed and graphs were plotted using Prism v10.2.3 (GraphPad).</p></sec><sec id="Sec24"><title>Reporting summary</title><p id="Par72">Further information on research design is available in the&#x000a0;<xref rid="MOESM3" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec id="Sec25" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2024_54399_MOESM1_ESM.pdf"><caption><p>Supplementary information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2024_54399_MOESM2_ESM.pdf"><caption><p>Transparent Peer Review file</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2024_54399_MOESM3_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2024_54399_MOESM4_ESM.pdf"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41467_2024_54399_MOESM5_ESM.xlsx"><caption><p>Supplementary Dataset 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41467_2024_54399_MOESM6_ESM.xlsx"><caption><p>Supplementary Dataset 2</p></caption></media></supplementary-material>
</p></sec><sec id="Sec26" sec-type="supplementary-material"><title>Source data</title><p>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41467_2024_54399_MOESM7_ESM.xlsx"><caption><p>Source Data</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p><bold>Change history</bold></p><p>2/27/2025</p><p id="Par1">This article was originally published under a CC BY-NC-ND 4.0 license, but has now been made available under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. license. The PDF and HTML versions of the paper have been modified accordingly.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-024-54399-4.</p></sec><ack><title>Acknowledgements</title><p>We thank J. Stefanovic, L. Cupak, and H. Freislebenova for their technical assistance, D. Zudova for histopathology analysis, and Michael R. H. Vorndran for help with cell death experiments analysis. This project was supported by a Czech Science Foundation grant (21-25251S), EMBO Installation grant (4420), and Charles University grant (PRIMUS/20/MED/003) awarded to P.D., European Union&#x02019;s Horizon 2020 research and innovation program under grant agreement No 802878 (ERC Starting Grant FunDiT) awarded to O.S., and Charles University grant (406322) awarded to M.P. We acknowledge Charles University institutional funding (Cooperation and UNCE/MED/016), core funding of the Institute of Molecular Genetics of the Czech Academy of Sciences, Czech Republic (IMG ASCR) (RVO 68378050), the project National Institute for Cancer Research (Program EXCELES, LX22NPO5102) and the project National Institute of virology and bacteriology (Program EXCELES, LX22NPO5103) - both funded by the European Union - Next Generation EU, and grant SVV 260637 provided by the Ministry of Education, Youth and Sports of the Czech Republic (MEYS). The project was further supported by grant LM2023036 from the MEYS provided to the Czech Center for Phenogenomics at IMG, ASCR and by the German Research Foundation (DFG) project SFB1403 (414786233) and by the German Federal Ministry of Education and Research (BMBF) project 16LW0213. A.U., M.P., and T.T. were students at the First Faculty of Medicine, and D.K., A.S., and V.N. were students at the Faculty of Science at Charles University in Prague.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>A.U., D.K., A.S., M.P., T.T., A.D., A.D., D.P., R.D.G., P.K., O.F. and O.M. planned, performed, and analyzed the experiments. V.N. performed RNAseq analysis. B.F.R. analyzed cell death experiments. J.P., J.L., Z.T., R.S. and O.S. supervised the experiments. P.D. conceived the study and wrote the manuscript. All authors commented on the manuscript draft.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par73"><italic>Nature Communications</italic> thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>The bulk RNA sequencing data have been deposited in Sequence Read Archive (SRA) under the accession code <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1095284">PRJNA1095284</ext-link>.&#x000a0;<xref ref-type="sec" rid="Sec26">Source data</xref> are provided with this paper.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>The code for the custom-made software CellLocator v0.9.2 used to determine the percentage of cell death in high-throughput live cell imaging data can be accessed in the public repository Zenodo<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> [<ext-link ext-link-type="uri" xlink:href="https://zenodo.org/records/13774183">https://zenodo.org/records/13774183</ext-link>]. Source data are provided with this publication.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par74">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Kupka</surname><given-names>S</given-names></name><name><surname>Reichert</surname><given-names>M</given-names></name><name><surname>Draber</surname><given-names>P</given-names></name><name><surname>Walczak</surname><given-names>H</given-names></name></person-group><article-title>Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death</article-title><source>FEBS J</source><year>2016</year><volume>283</volume><fpage>2626</fpage><lpage>2639</lpage><pub-id pub-id-type="doi">10.1111/febs.13644</pub-id><pub-id pub-id-type="pmid">26749412</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Kupka, S., Reichert, M., Draber, P. &#x00026; Walczak, H. Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death. <italic>FEBS J</italic><bold>283</bold>, 2626&#x02013;2639 (2016).<pub-id pub-id-type="pmid">26749412</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Micheau</surname><given-names>O</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><article-title>Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes</article-title><source>Cell</source><year>2003</year><volume>114</volume><fpage>181</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00521-X</pub-id><pub-id pub-id-type="pmid">12887920</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Micheau, O. &#x00026; Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. <italic>Cell</italic><bold>114</bold>, 181&#x02013;190 (2003).<pub-id pub-id-type="pmid">12887920</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Degterev</surname><given-names>A</given-names></name><etal/></person-group><article-title>Identification of RIP1 kinase as a specific cellular target of necrostatins</article-title><source>Nat Chem Biol</source><year>2008</year><volume>4</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1038/nchembio.83</pub-id><pub-id pub-id-type="pmid">18408713</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. <italic>Nat Chem Biol</italic><bold>4</bold>, 313&#x02013;321 (2008).<pub-id pub-id-type="pmid">18408713</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YS</given-names></name><etal/></person-group><article-title>Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation</article-title><source>Cell</source><year>2009</year><volume>137</volume><fpage>1112</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.05.037</pub-id><pub-id pub-id-type="pmid">19524513</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. <italic>Cell</italic><bold>137</bold>, 1112&#x02013;1123 (2009).<pub-id pub-id-type="pmid">19524513</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><etal/></person-group><article-title>Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha</article-title><source>Cell</source><year>2009</year><volume>137</volume><fpage>1100</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.05.021</pub-id><pub-id pub-id-type="pmid">19524512</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. <italic>Cell</italic><bold>137</bold>, 1100&#x02013;1111 (2009).<pub-id pub-id-type="pmid">19524512</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>DW</given-names></name><etal/></person-group><article-title>RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>332</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1126/science.1172308</pub-id><pub-id pub-id-type="pmid">19498109</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. <italic>Science</italic><bold>325</bold>, 332&#x02013;336 (2009).<pub-id pub-id-type="pmid">19498109</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><etal/></person-group><article-title>Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase</article-title><source>Cell</source><year>2012</year><volume>148</volume><fpage>213</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.11.031</pub-id><pub-id pub-id-type="pmid">22265413</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. <italic>Cell</italic><bold>148</bold>, 213&#x02013;227 (2012).<pub-id pub-id-type="pmid">22265413</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis</article-title><source>Nat Cell Biol</source><year>2014</year><volume>16</volume><fpage>55</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/ncb2883</pub-id><pub-id pub-id-type="pmid">24316671</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Cai, Z. et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. <italic>Nat Cell Biol</italic><bold>16</bold>, 55&#x02013;65 (2014).<pub-id pub-id-type="pmid">24316671</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Varfolomeev</surname><given-names>E</given-names></name><name><surname>Vucic</surname><given-names>D</given-names></name></person-group><article-title>RIP1 post-translational modifications</article-title><source>Biochem J</source><year>2022</year><volume>479</volume><fpage>929</fpage><lpage>951</lpage><pub-id pub-id-type="doi">10.1042/BCJ20210725</pub-id><pub-id pub-id-type="pmid">35522161</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Varfolomeev, E. &#x00026; Vucic, D. RIP1 post-translational modifications. <italic>Biochem J</italic><bold>479</bold>, 929&#x02013;951 (2022).<pub-id pub-id-type="pmid">35522161</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Dondelinger</surname><given-names>Y</given-names></name><etal/></person-group><article-title>NF-kappaB-Independent Role of IKKalpha/IKKbeta in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling</article-title><source>Mol Cell</source><year>2015</year><volume>60</volume><fpage>63</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2015.07.032</pub-id><pub-id pub-id-type="pmid">26344099</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Dondelinger, Y. et al. NF-kappaB-Independent Role of IKKalpha/IKKbeta in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. <italic>Mol Cell</italic><bold>60</bold>, 63&#x02013;76 (2015).<pub-id pub-id-type="pmid">26344099</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>J</given-names></name><etal/></person-group><article-title>Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis</article-title><source>Nat Commun</source><year>2017</year><volume>8</volume><fpage>359</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-00406-w</pub-id><pub-id pub-id-type="pmid">28842570</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Geng, J. et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. <italic>Nat Commun</italic><bold>8</bold>, 359 (2017).<pub-id pub-id-type="pmid">28842570</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Jaco</surname><given-names>I</given-names></name><etal/></person-group><article-title>MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death</article-title><source>Mol Cell</source><year>2017</year><volume>66</volume><fpage>698</fpage><lpage>710.e695</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.05.003</pub-id><pub-id pub-id-type="pmid">28506461</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Jaco, I. et al. MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death. <italic>Mol Cell</italic><bold>66</bold>, 698&#x02013;710.e695 (2017).<pub-id pub-id-type="pmid">28506461</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>MB</given-names></name><etal/></person-group><article-title>p38(MAPK)/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection</article-title><source>Nat Cell Biol</source><year>2017</year><volume>19</volume><fpage>1248</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1038/ncb3614</pub-id><pub-id pub-id-type="pmid">28920954</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Menon, M. B. et al. p38(MAPK)/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. <italic>Nat Cell Biol</italic><bold>19</bold>, 1248&#x02013;1259 (2017).<pub-id pub-id-type="pmid">28920954</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Dondelinger</surname><given-names>Y</given-names></name><etal/></person-group><article-title>MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death</article-title><source>Nat Cell Biol</source><year>2017</year><volume>19</volume><fpage>1237</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1038/ncb3608</pub-id><pub-id pub-id-type="pmid">28920952</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Dondelinger, Y. et al. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. <italic>Nat Cell Biol</italic><bold>19</bold>, 1237&#x02013;1247 (2017).<pub-id pub-id-type="pmid">28920952</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Kirisako</surname><given-names>T</given-names></name><etal/></person-group><article-title>A ubiquitin ligase complex assembles linear polyubiquitin chains</article-title><source>EMBO J</source><year>2006</year><volume>25</volume><fpage>4877</fpage><lpage>4887</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601360</pub-id><pub-id pub-id-type="pmid">17006537</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Kirisako, T. et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. <italic>EMBO J</italic><bold>25</bold>, 4877&#x02013;4887 (2006).<pub-id pub-id-type="pmid">17006537</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction</article-title><source>Mol Cell</source><year>2009</year><volume>36</volume><fpage>831</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2009.10.013</pub-id><pub-id pub-id-type="pmid">20005846</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Haas, T. L. et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. <italic>Mol Cell</italic><bold>36</bold>, 831&#x02013;844 (2009).<pub-id pub-id-type="pmid">20005846</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Kanayama</surname><given-names>A</given-names></name><etal/></person-group><article-title>TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains</article-title><source>Mol Cell</source><year>2004</year><volume>15</volume><fpage>535</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.08.008</pub-id><pub-id pub-id-type="pmid">15327770</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Kanayama, A. et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. <italic>Mol Cell</italic><bold>15</bold>, 535&#x02013;548 (2004).<pub-id pub-id-type="pmid">15327770</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Rahighi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation</article-title><source>Cell</source><year>2009</year><volume>136</volume><fpage>1098</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.03.007</pub-id><pub-id pub-id-type="pmid">19303852</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. <italic>Cell</italic><bold>136</bold>, 1098&#x02013;1109 (2009).<pub-id pub-id-type="pmid">19303852</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Draber</surname><given-names>P</given-names></name><etal/></person-group><article-title>LUBAC-Recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes</article-title><source>Cell Rep</source><year>2015</year><volume>13</volume><fpage>2258</fpage><lpage>2272</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.11.009</pub-id><pub-id pub-id-type="pmid">26670046</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Draber, P. et al. LUBAC-Recruited CYLD and A20 regulate gene activation and cell death by exerting opposing effects on linear ubiquitin in signaling complexes. <italic>Cell Rep</italic><bold>13</bold>, 2258&#x02013;2272 (2015).<pub-id pub-id-type="pmid">26670046</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D</given-names></name><etal/></person-group><article-title>TBK1 suppresses RIPK1-Driven apoptosis and inflammation during development and in aging</article-title><source>Cell</source><year>2018</year><volume>174</volume><fpage>1477</fpage><lpage>1491.e19</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.041</pub-id><pub-id pub-id-type="pmid">30146158</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Xu, D. et al. TBK1 suppresses RIPK1-Driven apoptosis and inflammation during development and in aging. <italic>Cell</italic><bold>174</bold>, 1477&#x02013;1491.e19 (2018).<pub-id pub-id-type="pmid">30146158</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>K</given-names></name><etal/></person-group><article-title>Novel cross-talk within the IKK family controls innate immunity</article-title><source>Biochem J</source><year>2011</year><volume>434</volume><fpage>93</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1042/BJ20101701</pub-id><pub-id pub-id-type="pmid">21138416</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Clark, K. et al. Novel cross-talk within the IKK family controls innate immunity. <italic>Biochem J</italic><bold>434</bold>, 93&#x02013;104 (2011).<pub-id pub-id-type="pmid">21138416</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Lafont</surname><given-names>E</given-names></name><etal/></person-group><article-title>TBK1 and IKKepsilon prevent TNF-induced cell death by RIPK1 phosphorylation</article-title><source>Nat Cell Biol</source><year>2018</year><volume>20</volume><fpage>1389</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0229-6</pub-id><pub-id pub-id-type="pmid">30420664</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Lafont, E. et al. TBK1 and IKKepsilon prevent TNF-induced cell death by RIPK1 phosphorylation. <italic>Nat Cell Biol</italic><bold>20</bold>, 1389&#x02013;1399 (2018).<pub-id pub-id-type="pmid">30420664</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>van Loo</surname><given-names>G</given-names></name><name><surname>Bertrand</surname><given-names>MJM</given-names></name></person-group><article-title>Death by TNF: a road to inflammation</article-title><source>Nat Rev Immunol</source><year>2023</year><volume>23</volume><fpage>289</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1038/s41577-022-00792-3</pub-id><pub-id pub-id-type="pmid">36380021</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">van Loo, G. &#x00026; Bertrand, M. J. M. Death by TNF: a road to inflammation. <italic>Nat Rev Immunol</italic><bold>23</bold>, 289&#x02013;303 (2023).<pub-id pub-id-type="pmid">36380021</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnard</surname><given-names>M</given-names></name><etal/></person-group><article-title>Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>4976</fpage><lpage>4985</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.18.4976</pub-id><pub-id pub-id-type="pmid">10990461</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Bonnard, M. et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. <italic>EMBO J</italic><bold>19</bold>, 4976&#x02013;4985 (2000).<pub-id pub-id-type="pmid">10990461</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Eren</surname><given-names>RO</given-names></name><name><surname>Kaya</surname><given-names>GG</given-names></name><name><surname>Schwarzer</surname><given-names>R</given-names></name><name><surname>Pasparakis</surname><given-names>M</given-names></name></person-group><article-title>IKKepsilon and TBK1 prevent RIPK1 dependent and independent inflammation</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><fpage>130</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-44372-y</pub-id><pub-id pub-id-type="pmid">38167258</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Eren, R. O., Kaya, G. G., Schwarzer, R. &#x00026; Pasparakis, M. IKKepsilon and TBK1 prevent RIPK1 dependent and independent inflammation. <italic>Nat Commun</italic><bold>15</bold>, 130 (2024).<pub-id pub-id-type="pmid">38167258</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Marchlik</surname><given-names>E</given-names></name><etal/></person-group><article-title>Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality</article-title><source>J Leukoc Biol</source><year>2010</year><volume>88</volume><fpage>1171</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1189/jlb.0210071</pub-id><pub-id pub-id-type="pmid">20651301</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Marchlik, E. et al. Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality. <italic>J Leukoc Biol</italic><bold>88</bold>, 1171&#x02013;1180 (2010).<pub-id pub-id-type="pmid">20651301</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Taft</surname><given-names>J</given-names></name><etal/></person-group><article-title>Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>4447</fpage><lpage>4463.e20</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.07.026</pub-id><pub-id pub-id-type="pmid">34363755</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Taft, J. et al. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death. <italic>Cell</italic><bold>184</bold>, 4447&#x02013;4463.e20 (2021).<pub-id pub-id-type="pmid">34363755</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Sun, Y. et al. Targeting TBK1 to overcome resistance to cancer immunotherapy. <italic>Nature</italic><bold>615</bold>, 158&#x02013;167 (2023).</mixed-citation></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Runde</surname><given-names>AP</given-names></name><name><surname>Mack</surname><given-names>R</given-names></name><name><surname>S</surname><given-names>JP</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name></person-group><article-title>The role of TBK1 in cancer pathogenesis and anticancer immunity</article-title><source>J Exp Clin Cancer Res</source><year>2022</year><volume>41</volume><fpage>135</fpage><pub-id pub-id-type="doi">10.1186/s13046-022-02352-y</pub-id><pub-id pub-id-type="pmid">35395857</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Runde, A. P., Mack, R., S, J. P. &#x00026; Zhang, J. The role of TBK1 in cancer pathogenesis and anticancer immunity. <italic>J Exp Clin Cancer Res</italic><bold>41</bold>, 135 (2022).<pub-id pub-id-type="pmid">35395857</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>P</given-names></name><etal/></person-group><article-title>Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth</article-title><source>Science</source><year>2011</year><volume>333</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1126/science.1205405</pub-id><pub-id pub-id-type="pmid">21617041</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Wild, P. et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. <italic>Science</italic><bold>333</bold>, 228&#x02013;233 (2011).<pub-id pub-id-type="pmid">21617041</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>R</given-names></name><etal/></person-group><article-title>MAVS activates TBK1 and IKKepsilon through TRAFs in NEMO dependent and independent manner</article-title><source>PLoS Pathog</source><year>2017</year><volume>13</volume><fpage>e1006720</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1006720</pub-id><pub-id pub-id-type="pmid">29125880</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Fang, R. et al. MAVS activates TBK1 and IKKepsilon through TRAFs in NEMO dependent and independent manner. <italic>PLoS Pathog</italic><bold>13</bold>, e1006720 (2017).<pub-id pub-id-type="pmid">29125880</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Structural basis of STING binding with and phosphorylation by TBK1</article-title><source>Nature</source><year>2019</year><volume>567</volume><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1000-2</pub-id><pub-id pub-id-type="pmid">30842653</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Zhang, C. et al. Structural basis of STING binding with and phosphorylation by TBK1. <italic>Nature</italic><bold>567</bold>, 394&#x02013;398 (2019).<pub-id pub-id-type="pmid">30842653</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Kawagoe</surname><given-names>T</given-names></name><etal/></person-group><article-title>TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis</article-title><source>Nat Immunol</source><year>2009</year><volume>10</volume><fpage>965</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/ni.1771</pub-id><pub-id pub-id-type="pmid">19668221</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Kawagoe, T. et al. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. <italic>Nat Immunol</italic><bold>10</bold>, 965&#x02013;972 (2009).<pub-id pub-id-type="pmid">19668221</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Fukasaka</surname><given-names>M</given-names></name><etal/></person-group><article-title>Critical role of AZI2 in GM-CSF-induced dendritic cell differentiation</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><fpage>5702</fpage><lpage>5711</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203155</pub-id><pub-id pub-id-type="pmid">23610142</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Fukasaka, M. et al. Critical role of AZI2 in GM-CSF-induced dendritic cell differentiation. <italic>J Immunol</italic><bold>190</bold>, 5702&#x02013;5711 (2013).<pub-id pub-id-type="pmid">23610142</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><etal/></person-group><article-title>Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>9378</fpage><lpage>9383</lpage><pub-id pub-id-type="doi">10.1073/pnas.1121552109</pub-id><pub-id pub-id-type="pmid">22619329</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Ma, X. et al. Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. <italic>Proc Natl Acad Sci USA</italic><bold>109</bold>, 9378&#x02013;9383 (2012).<pub-id pub-id-type="pmid">22619329</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Kishore</surname><given-names>N</given-names></name><etal/></person-group><article-title>IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>13840</fpage><lpage>13847</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110474200</pub-id><pub-id pub-id-type="pmid">11839743</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Kishore, N. et al. IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2. <italic>J Biol Chem</italic><bold>277</bold>, 13840&#x02013;13847 (2002).<pub-id pub-id-type="pmid">11839743</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Joo</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>SC</given-names></name></person-group><article-title>NF-kappaB signaling in inflammation</article-title><source>Signal Transduct Target Ther</source><year>2017</year><volume>2</volume><fpage>17023</fpage><pub-id pub-id-type="doi">10.1038/sigtrans.2017.23</pub-id><pub-id pub-id-type="pmid">29158945</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Liu, T., Zhang, L., Joo, D. &#x00026; Sun, S. C. NF-kappaB signaling in inflammation. <italic>Signal Transduct Target Ther</italic><bold>2</bold>, 17023 (2017).<pub-id pub-id-type="pmid">29158945</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Dissecting the regulatory strategies of NF-kappaB RelA target genes in the inflammatory response reveals differential transactivation logics</article-title><source>Cell Rep</source><year>2020</year><volume>30</volume><fpage>2758</fpage><lpage>2775.e2756</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2020.01.108</pub-id><pub-id pub-id-type="pmid">32101750</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Ngo, K. A. et al. Dissecting the regulatory strategies of NF-kappaB RelA target genes in the inflammatory response reveals differential transactivation logics. <italic>Cell Rep</italic><bold>30</bold>, 2758&#x02013;2775.e2756 (2020).<pub-id pub-id-type="pmid">32101750</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Karin</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>A</given-names></name></person-group><article-title>NF-kappaB at the crossroads of life and death</article-title><source>Nat Immunol</source><year>2002</year><volume>3</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1038/ni0302-221</pub-id><pub-id pub-id-type="pmid">11875461</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Karin, M. &#x00026; Lin, A. NF-kappaB at the crossroads of life and death. <italic>Nat Immunol</italic><bold>3</bold>, 221&#x02013;227 (2002).<pub-id pub-id-type="pmid">11875461</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Le Hir</surname><given-names>M</given-names></name><etal/></person-group><article-title>Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling</article-title><source>J Exp Med</source><year>1996</year><volume>183</volume><fpage>2367</fpage><lpage>2372</lpage><pub-id pub-id-type="doi">10.1084/jem.183.5.2367</pub-id><pub-id pub-id-type="pmid">8642347</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Le Hir, M. et al. Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. <italic>J Exp Med</italic><bold>183</bold>, 2367&#x02013;2372 (1996).<pub-id pub-id-type="pmid">8642347</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Polykratis</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo</article-title><source>J Immunol</source><year>2014</year><volume>193</volume><fpage>1539</fpage><lpage>1543</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1400590</pub-id><pub-id pub-id-type="pmid">25015821</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Polykratis, A. et al. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. <italic>J Immunol</italic><bold>193</bold>, 1539&#x02013;1543 (2014).<pub-id pub-id-type="pmid">25015821</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Cicognani</surname><given-names>C</given-names></name><etal/></person-group><article-title>Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis</article-title><source>Arch Intern Med</source><year>1997</year><volume>157</volume><fpage>792</fpage><lpage>796</lpage><pub-id pub-id-type="doi">10.1001/archinte.1997.00440280120012</pub-id><pub-id pub-id-type="pmid">9125012</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Cicognani, C. et al. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. <italic>Arch Intern Med</italic><bold>157</bold>, 792&#x02013;796 (1997).<pub-id pub-id-type="pmid">9125012</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Moustafa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury</article-title><source>Gastroenterology</source><year>2012</year><volume>142</volume><fpage>140</fpage><lpage>151.e112</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2011.09.051</pub-id><pub-id pub-id-type="pmid">22001865</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Moustafa, T. et al. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. <italic>Gastroenterology</italic><bold>142</bold>, 140&#x02013;151.e112 (2012).<pub-id pub-id-type="pmid">22001865</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Ryzhakov</surname><given-names>G</given-names></name><name><surname>Randow</surname><given-names>F</given-names></name></person-group><article-title>SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><fpage>3180</fpage><lpage>3190</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601743</pub-id><pub-id pub-id-type="pmid">17568778</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Ryzhakov, G. &#x00026; Randow, F. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. <italic>EMBO J</italic><bold>26</bold>, 3180&#x02013;3190 (2007).<pub-id pub-id-type="pmid">17568778</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Chariot</surname><given-names>A</given-names></name><etal/></person-group><article-title>Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>37029</fpage><lpage>37036</lpage><pub-id pub-id-type="doi">10.1074/jbc.M205069200</pub-id><pub-id pub-id-type="pmid">12133833</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Chariot, A. et al. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. <italic>J Biol Chem</italic><bold>277</bold>, 37029&#x02013;37036 (2002).<pub-id pub-id-type="pmid">12133833</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>K</given-names></name><name><surname>Takeuchi</surname><given-names>O</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name></person-group><article-title>The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>17093</fpage><lpage>17098</lpage><pub-id pub-id-type="doi">10.1073/pnas.1114194108</pub-id><pub-id pub-id-type="pmid">21949249</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Clark, K., Takeuchi, O., Akira, S. &#x00026; Cohen, P. The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling. <italic>Proc Natl Acad Sci USA</italic><bold>108</bold>, 17093&#x02013;17098 (2011).<pub-id pub-id-type="pmid">21949249</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Bosanac</surname><given-names>I</given-names></name><etal/></person-group><article-title>Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling</article-title><source>Mol Cell</source><year>2010</year><volume>40</volume><fpage>548</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.10.009</pub-id><pub-id pub-id-type="pmid">21095585</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Bosanac, I. et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling. <italic>Mol Cell</italic><bold>40</bold>, 548&#x02013;557 (2010).<pub-id pub-id-type="pmid">21095585</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname><given-names>F</given-names></name><etal/></person-group><article-title>Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-kappaB regulation</article-title><source>EMBO J</source><year>2012</year><volume>31</volume><fpage>3856</fpage><lpage>3870</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.241</pub-id><pub-id pub-id-type="pmid">23032187</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Tokunaga, F. et al. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-kappaB regulation. <italic>EMBO J</italic><bold>31</bold>, 3856&#x02013;3870 (2012).<pub-id pub-id-type="pmid">23032187</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Draberova</surname><given-names>H</given-names></name><etal/></person-group><article-title>Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loop</article-title><source>EMBO J</source><year>2020</year><volume>39</volume><fpage>e104202</fpage><pub-id pub-id-type="doi">10.15252/embj.2019104202</pub-id><pub-id pub-id-type="pmid">32696476</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Draberova, H. et al. Systematic analysis of the IL-17 receptor signalosome reveals a robust regulatory feedback loop. <italic>EMBO J</italic><bold>39</bold>, e104202 (2020).<pub-id pub-id-type="pmid">32696476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YG</given-names></name><etal/></person-group><article-title>LUBAC enables tumor-promoting LTbeta receptor signaling by activating canonical NF-kappaB</article-title><source>Cell Death Differ</source><year>2024</year><pub-id pub-id-type="doi">10.1038/s41418-024-01355-w</pub-id><pub-id pub-id-type="pmid">39672819</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Chen, Y. G. et al. LUBAC enables tumor-promoting LTbeta receptor signaling by activating canonical NF-kappaB. <italic>Cell Death Differ</italic>10.1038/s41418-024-01355-w (2024).<pub-id pub-id-type="pmid">39672819</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Schweizer</surname><given-names>P</given-names></name><name><surname>Kalhoff</surname><given-names>H</given-names></name><name><surname>Horneff</surname><given-names>G</given-names></name><name><surname>Wahn</surname><given-names>V</given-names></name><name><surname>Diekmann</surname><given-names>L</given-names></name></person-group><article-title>[Polysaccharide specific humoral immunodeficiency in ectodermal dysplasia. Case report of a boy with two affected brothers]</article-title><source>Klin Padiatr</source><year>1999</year><volume>211</volume><fpage>459</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1055/s-2008-1043834</pub-id><pub-id pub-id-type="pmid">10592927</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Schweizer, P., Kalhoff, H., Horneff, G., Wahn, V. &#x00026; Diekmann, L. [Polysaccharide specific humoral immunodeficiency in ectodermal dysplasia. Case report of a boy with two affected brothers]. <italic>Klin Padiatr</italic><bold>211</bold>, 459&#x02013;461 (1999).<pub-id pub-id-type="pmid">10592927</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Doffinger</surname><given-names>R</given-names></name><etal/></person-group><article-title>X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling</article-title><source>Nat Genet</source><year>2001</year><volume>27</volume><fpage>277</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1038/85837</pub-id><pub-id pub-id-type="pmid">11242109</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Doffinger, R. et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. <italic>Nat Genet</italic><bold>27</bold>, 277&#x02013;285 (2001).<pub-id pub-id-type="pmid">11242109</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>F</given-names></name><etal/></person-group><article-title>Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling</article-title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><fpage>7780</fpage><lpage>7793</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.21.7780-7793.2003</pub-id><pub-id pub-id-type="pmid">14560022</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Fujita, F. et al. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. <italic>Mol Cell Biol</italic><bold>23</bold>, 7780&#x02013;7793 (2003).<pub-id pub-id-type="pmid">14560022</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>F</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Nakanishi</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation</article-title><source>Genes Cells</source><year>2000</year><volume>5</volume><fpage>191</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2443.2000.00315.x</pub-id><pub-id pub-id-type="pmid">10759890</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Nomura, F., Kawai, T., Nakanishi, K. &#x00026; Akira, S. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. <italic>Genes Cells</italic><bold>5</bold>, 191&#x02013;202 (2000).<pub-id pub-id-type="pmid">10759890</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>A</given-names></name><etal/></person-group><article-title>Functional dissection of the TBK1 molecular network</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e23971</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0023971</pub-id><pub-id pub-id-type="pmid">21931631</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Goncalves, A. et al. Functional dissection of the TBK1 molecular network. <italic>PLoS One</italic><bold>6</bold>, e23971 (2011).<pub-id pub-id-type="pmid">21931631</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmi</surname><given-names>H</given-names></name><etal/></person-group><article-title>The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection</article-title><source>J Exp Med</source><year>2004</year><volume>199</volume><fpage>1641</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1084/jem.20040520</pub-id><pub-id pub-id-type="pmid">15210742</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Hemmi, H. et al. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. <italic>J Exp Med</italic><bold>199</bold>, 1641&#x02013;1650 (2004).<pub-id pub-id-type="pmid">15210742</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J</given-names></name><etal/></person-group><article-title>The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-kappaB signaling</article-title><source>Nat Immunol</source><year>2012</year><volume>13</volume><fpage>1101</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1038/ni.2423</pub-id><pub-id pub-id-type="pmid">23023393</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Jin, J. et al. The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-kappaB signaling. <italic>Nat Immunol</italic><bold>13</bold>, 1101&#x02013;1109 (2012).<pub-id pub-id-type="pmid">23023393</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><etal/></person-group><article-title>RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system</article-title><source>Elife</source><year>2017</year><volume>6</volume><fpage>e27692</fpage><pub-id pub-id-type="doi">10.7554/eLife.27692</pub-id><pub-id pub-id-type="pmid">28807105</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Li, D. et al. RIPK1-RIPK3-MLKL-dependent necrosis promotes the aging of mouse male reproductive system. <italic>Elife</italic><bold>6</bold>, e27692 (2017).<pub-id pub-id-type="pmid">28807105</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Zilberman-Rudenko</surname><given-names>J</given-names></name><etal/></person-group><article-title>Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-kappaB activation and autoinflammatory disease</article-title><source>Proc Natl Acad Sci USA</source><year>2016</year><volume>113</volume><fpage>1612</fpage><lpage>1617</lpage><pub-id pub-id-type="doi">10.1073/pnas.1518163113</pub-id><pub-id pub-id-type="pmid">26802121</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Zilberman-Rudenko, J. et al. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-kappaB activation and autoinflammatory disease. <italic>Proc Natl Acad Sci USA</italic><bold>113</bold>, 1612&#x02013;1617 (2016).<pub-id pub-id-type="pmid">26802121</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>H</given-names></name><name><surname>Xiong</surname><given-names>J</given-names></name><name><surname>Goeddel</surname><given-names>DV</given-names></name></person-group><article-title>The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation</article-title><source>Cell</source><year>1995</year><volume>81</volume><fpage>495</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90070-5</pub-id><pub-id pub-id-type="pmid">7758105</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Hsu, H., Xiong, J. &#x00026; Goeddel, D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. <italic>Cell</italic><bold>81</bold>, 495&#x02013;504 (1995).<pub-id pub-id-type="pmid">7758105</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Pobezinskaya</surname><given-names>YL</given-names></name><etal/></person-group><article-title>The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors</article-title><source>Nat Immunol</source><year>2008</year><volume>9</volume><fpage>1047</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1038/ni.1639</pub-id><pub-id pub-id-type="pmid">18641653</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Pobezinskaya, Y. L. et al. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. <italic>Nat Immunol</italic><bold>9</bold>, 1047&#x02013;1054 (2008).<pub-id pub-id-type="pmid">18641653</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Ermolaeva</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses</article-title><source>Nat Immunol</source><year>2008</year><volume>9</volume><fpage>1037</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1038/ni.1638</pub-id><pub-id pub-id-type="pmid">18641654</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Ermolaeva, M. A. et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. <italic>Nat Immunol</italic><bold>9</bold>, 1037&#x02013;1046 (2008).<pub-id pub-id-type="pmid">18641654</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. <italic>Nature</italic><bold>596</bold>, 583&#x02013;589 (2021).<pub-id pub-id-type="pmid">34265844</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Taraborrelli</surname><given-names>L</given-names></name><name><surname>Walczak</surname><given-names>H</given-names></name></person-group><article-title>Linear ubiquitination in immunity</article-title><source>Immunol Rev</source><year>2015</year><volume>266</volume><fpage>190</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1111/imr.12309</pub-id><pub-id pub-id-type="pmid">26085216</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Shimizu, Y., Taraborrelli, L. &#x00026; Walczak, H. Linear ubiquitination in immunity. <italic>Immunol Rev</italic><bold>266</bold>, 190&#x02013;207 (2015).<pub-id pub-id-type="pmid">26085216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Gitlin</surname><given-names>AD</given-names></name><etal/></person-group><article-title>N4BP1 coordinates ubiquitin-dependent crosstalk within the IkappaB kinase family to limit Toll-like receptor signaling and inflammation</article-title><source>Immunity</source><year>2024</year><volume>57</volume><fpage>973</fpage><lpage>986.e977</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2024.04.004</pub-id><pub-id pub-id-type="pmid">38697117</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Gitlin, A. D. et al. N4BP1 coordinates ubiquitin-dependent crosstalk within the IkappaB kinase family to limit Toll-like receptor signaling and inflammation. <italic>Immunity</italic><bold>57</bold>, 973&#x02013;986.e977 (2024).<pub-id pub-id-type="pmid">38697117</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>T</given-names></name><etal/></person-group><article-title>Myeloid cell TBK1 restricts inflammatory responses</article-title><source>Proc Natl Acad Sci USA</source><year>2022</year><volume>119</volume><fpage>e2107742119</fpage><pub-id pub-id-type="doi">10.1073/pnas.2107742119</pub-id><pub-id pub-id-type="pmid">35074921</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Gao, T. et al. Myeloid cell TBK1 restricts inflammatory responses. <italic>Proc Natl Acad Sci USA</italic><bold>119</bold>, e2107742119 (2022).<pub-id pub-id-type="pmid">35074921</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Labun</surname><given-names>K</given-names></name><etal/></person-group><article-title>CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing</article-title><source>Nucleic Acids Res</source><year>2019</year><volume>47</volume><fpage>W171</fpage><lpage>W174</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz365</pub-id><pub-id pub-id-type="pmid">31106371</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Labun, K. et al. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. <italic>Nucleic Acids Res</italic><bold>47</bold>, W171&#x02013;W174 (2019).<pub-id pub-id-type="pmid">31106371</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Ran</surname><given-names>FA</given-names></name><etal/></person-group><article-title>Genome engineering using the CRISPR-Cas9 system</article-title><source>Nat Protoc</source><year>2013</year><volume>8</volume><fpage>2281</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id><pub-id pub-id-type="pmid">24157548</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. <italic>Nat Protoc</italic><bold>8</bold>, 2281&#x02013;2308 (2013).<pub-id pub-id-type="pmid">24157548</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="other">Vorndran, M. R. H. &#x00026; Roeck, B. F. Inconsistency Masks: Removing the Uncertainty from Input-Pseudo-Label Pairs. arXiv:2401.14387 <ext-link ext-link-type="uri" xlink:href="https://ui.adsabs.harvard.edu/abs/2024arXiv240114387V">https://ui.adsabs.harvard.edu/abs/2024arXiv240114387V</ext-link> (2024).</mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="other">Vorndran, M. R. H. &#x00026; Roeck, B. F. MichaelVorndran/CellLocator: CellLocator v0.9.2 (v0.9.2). Zenodo. 10.5281/zenodo.13774183 (2024).</mixed-citation></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name><name><surname>Lundin</surname><given-names>S</given-names></name><name><surname>Kaller</surname><given-names>M</given-names></name></person-group><article-title>MultiQC: summarize analysis results for multiple tools and samples in a single report</article-title><source>Bioinformatics</source><year>2016</year><volume>32</volume><fpage>3047</fpage><lpage>3048</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw354</pub-id><pub-id pub-id-type="pmid">27312411</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Ewels, P., Magnusson, M., Lundin, S. &#x00026; Kaller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. <italic>Bioinformatics</italic><bold>32</bold>, 3047&#x02013;3048 (2016).<pub-id pub-id-type="pmid">27312411</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Patro</surname><given-names>R</given-names></name><name><surname>Duggal</surname><given-names>G</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Kingsford</surname><given-names>C</given-names></name></person-group><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title><source>Nat Methods</source><year>2017</year><volume>14</volume><fpage>417</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4197</pub-id><pub-id pub-id-type="pmid">28263959</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. &#x00026; Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. <italic>Nat Methods</italic><bold>14</bold>, 417&#x02013;419 (2017).<pub-id pub-id-type="pmid">28263959</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Soneson</surname><given-names>C</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Robinson</surname><given-names>MD</given-names></name></person-group><article-title>Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences</article-title><source>F1000Res</source><year>2015</year><volume>4</volume><fpage>1521</fpage><pub-id pub-id-type="doi">10.12688/f1000research.7563.1</pub-id><pub-id pub-id-type="pmid">26925227</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Soneson, C., Love, M. I. &#x00026; Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. <italic>F1000Res</italic><bold>4</bold>, 1521 (2015).<pub-id pub-id-type="pmid">26925227</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><fpage>550</fpage><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Love, M. I., Huber, W. &#x00026; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. <italic>Genome Biol</italic><bold>15</bold>, 550 (2014).<pub-id pub-id-type="pmid">25516281</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Jenickova</surname><given-names>I</given-names></name><etal/></person-group><article-title>Efficient allele conversion in mouse zygotes and primary cells based on electroporation of Cre protein</article-title><source>Methods</source><year>2021</year><volume>191</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2020.07.005</pub-id><pub-id pub-id-type="pmid">32717290</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Jenickova, I. et al. Efficient allele conversion in mouse zygotes and primary cells based on electroporation of Cre protein. <italic>Methods</italic><bold>191</bold>, 87&#x02013;94 (2021).<pub-id pub-id-type="pmid">32717290</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Kusari</surname><given-names>F</given-names></name><name><surname>Mihola</surname><given-names>O</given-names></name><name><surname>Schimenti</surname><given-names>JC</given-names></name><name><surname>Trachtulec</surname><given-names>Z</given-names></name></person-group><article-title>Meiotic epigenetic factor PRDM9 impacts sperm quality of hybrid mice</article-title><source>Reproduction</source><year>2020</year><volume>160</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1530/REP-19-0528</pub-id><pub-id pub-id-type="pmid">32272448</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Kusari, F., Mihola, O., Schimenti, J. C. &#x00026; Trachtulec, Z. Meiotic epigenetic factor PRDM9 impacts sperm quality of hybrid mice. <italic>Reproduction</italic><bold>160</bold>, 53&#x02013;64 (2020).<pub-id pub-id-type="pmid">32272448</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>